

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Premature Ovarian Insufficiency - an update on... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2069/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2069" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Premature Ovarian Insufficiency - an update on recent advances in understanding and management" />
    
            <meta name="og:title" content="F1000Research Article: Premature Ovarian Insufficiency - an update on recent advances in understanding and management.">
            <meta name="og:description" content="Read the latest article version by Saioa Torrealday, Pinar Kodaman, Lubna Pal, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12914">
            <meta name="article-id" content="11948">
            <meta name="dc.title" content="Premature Ovarian Insufficiency - an update on recent advances in understanding and management">
            <meta name="dc.description" content="Premature ovarian insufficiency is a complex and relatively poorly understood entity with a myriad of etiologies and multisystem sequelae that stem from premature deprivation of ovarian sex hormones. Timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency is vital to appropriately counsel and treat these patients. Prompt initiation of hormone therapy is critical to control the unsolicited menopausal symptoms that many women experience and to prevent long-term health complications. Despite ongoing efforts at improving our understanding of the mechanisms involved, any advancement in the field in recent decades has been modest at best and researchers remain thwarted by the complexity and heterogeneity of the underpinnings of this entity. In contrast, the practice of clinical medicine has made meaningful strides in providing assurance to the women with premature ovarian insufficiency that their quality of life as well as long-term health can be optimized through timely intervention. Ongoing research is clearly needed to allow pre-emptive identification of the at-risk population and to identify mechanisms that if addressed in a timely manner, can prolong ovarian function and physiology.">
            <meta name="dc.subject" content="premature ovarian insufficiency, POI, ovarian physiology, ovarian sex hormones">
            <meta name="dc.creator" content="Torrealday, Saioa">
            <meta name="dc.creator" content="Kodaman, Pinar">
            <meta name="dc.creator" content="Pal, Lubna">
            <meta name="dc.date" content="2017/11/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11948.1">
            <meta name="dc.source" content="F1000Research 2017 6:2069">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="premature ovarian insufficiency">
            <meta name="prism.keyword" content="POI">
            <meta name="prism.keyword" content="ovarian physiology">
            <meta name="prism.keyword" content="ovarian sex hormones">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/11/29">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2069">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11948.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2069">
            <meta name="citation_title" content="Premature Ovarian Insufficiency - an update on recent advances in understanding and management">
            <meta name="citation_abstract" content="Premature ovarian insufficiency is a complex and relatively poorly understood entity with a myriad of etiologies and multisystem sequelae that stem from premature deprivation of ovarian sex hormones. Timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency is vital to appropriately counsel and treat these patients. Prompt initiation of hormone therapy is critical to control the unsolicited menopausal symptoms that many women experience and to prevent long-term health complications. Despite ongoing efforts at improving our understanding of the mechanisms involved, any advancement in the field in recent decades has been modest at best and researchers remain thwarted by the complexity and heterogeneity of the underpinnings of this entity. In contrast, the practice of clinical medicine has made meaningful strides in providing assurance to the women with premature ovarian insufficiency that their quality of life as well as long-term health can be optimized through timely intervention. Ongoing research is clearly needed to allow pre-emptive identification of the at-risk population and to identify mechanisms that if addressed in a timely manner, can prolong ovarian function and physiology.">
            <meta name="citation_description" content="Premature ovarian insufficiency is a complex and relatively poorly understood entity with a myriad of etiologies and multisystem sequelae that stem from premature deprivation of ovarian sex hormones. Timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency is vital to appropriately counsel and treat these patients. Prompt initiation of hormone therapy is critical to control the unsolicited menopausal symptoms that many women experience and to prevent long-term health complications. Despite ongoing efforts at improving our understanding of the mechanisms involved, any advancement in the field in recent decades has been modest at best and researchers remain thwarted by the complexity and heterogeneity of the underpinnings of this entity. In contrast, the practice of clinical medicine has made meaningful strides in providing assurance to the women with premature ovarian insufficiency that their quality of life as well as long-term health can be optimized through timely intervention. Ongoing research is clearly needed to allow pre-emptive identification of the at-risk population and to identify mechanisms that if addressed in a timely manner, can prolong ovarian function and physiology.">
            <meta name="citation_keywords" content="premature ovarian insufficiency, POI, ovarian physiology, ovarian sex hormones">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Saioa Torrealday">
            <meta name="citation_author_institution" content="Division of Reproductive Endocrinology and Infertility, Department of Obstetrics &amp; Gynecology, Womack Army Medical Center, Fort Bragg, North Carolina, USA">
            <meta name="citation_author" content="Pinar Kodaman">
            <meta name="citation_author_institution" content="Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA">
            <meta name="citation_author" content="Lubna Pal">
            <meta name="citation_author_institution" content="Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA">
            <meta name="citation_publication_date" content="2017/11/29">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2069">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11948.1">
            <meta name="citation_firstpage" content="2069">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2069/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2069.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12914 /> <input type=hidden id=articleId name=articleId value=11948 /> <input type=hidden id=xmlUrl value="/articles/6-2069/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2069-v1.xml"> <input type=hidden id=article_uuid value=61c360ed-cf5c-449c-a9e7-ad9acca78b39 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Premature Ovarian Insufficiency - an update on recent advances in understanding and management"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11948.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11948.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2069"
  },
  "headline": "Premature Ovarian Insufficiency - an update on recent advances in understanding and management",
  "datePublished": "2017-11-29T16:33:53",
  "dateModified": "2017-11-29T16:33:53",
  "author": [
    {
      "@type": "Person",
      "name": "Saioa Torrealday"
    },    {
      "@type": "Person",
      "name": "Pinar Kodaman"
    },    {
      "@type": "Person",
      "name": "Lubna Pal"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Premature ovarian insufficiency is a complex and relatively poorly understood entity with a myriad of etiologies and multisystem sequelae that stem from premature deprivation of ovarian sex hormones. Timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency is vital to appropriately counsel and treat these patients. Prompt initiation of hormone therapy is critical to control the unsolicited menopausal symptoms that many women experience and to prevent long-term health complications. Despite ongoing efforts at improving our understanding of the mechanisms involved, any advancement in the field in recent decades has been modest at best and researchers remain thwarted by the complexity and heterogeneity of the underpinnings of this entity. In contrast, the practice of clinical medicine has made meaningful strides in providing assurance to the women with premature ovarian insufficiency that their quality of life as well as long-term health can be optimized through timely intervention. Ongoing research is clearly needed to allow pre-emptive identification of the at-risk population and to identify mechanisms that if addressed in a timely manner, can prolong ovarian function and physiology."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2069",
            "name": "Premature Ovarian Insufficiency - an update on recent advances in..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Premature Ovarian Insufficiency - an update on recent advances in... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12914 data-id=11948 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11948.1" data-recommended="" data-doi="10.12688/f1000research.11948.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2069/v1/pdf?article_uuid=61c360ed-cf5c-449c-a9e7-ad9acca78b39" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11948-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11948-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11948-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Torrealday S, Kodaman P and Pal L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2069 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11948.1" target=_blank>https://doi.org/10.12688/f1000research.11948.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11948-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11948 id=track-article-signin-11948 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11948?target=/articles/6-2069">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12914 /> <input name=articleId type=hidden value=11948 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Premature Ovarian Insufficiency - an update on recent advances in understanding and management</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Saioa Torrealday<a href="https://orcid.org/0000-0003-3028-8896" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3028-8896</div><sup>1</sup>,&nbsp;</span><span class="">Pinar Kodaman<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:lubna.pal@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lubna Pal</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Saioa Torrealday<a href="http://orcid.org/0000-0003-3028-8896" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3028-8896</div><sup>1</sup>,&nbsp;</span><span class="">Pinar Kodaman<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:lubna.pal@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lubna Pal</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Nov 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11948.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics &amp; Gynecology, Womack Army Medical Center, Fort Bragg, North Carolina, USA<br/> <sup>2</sup> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA<br/> <p> <div class=margin-bottom> Saioa Torrealday <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Pinar Kodaman <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Lubna Pal <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28390-28316></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=11187-28318></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28389-28317></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Premature ovarian insufficiency is a complex and relatively poorly understood entity with a myriad of etiologies and multisystem sequelae that stem from premature deprivation of ovarian sex hormones. Timely diagnosis with a clear understanding of the various comorbidities that can arise from estrogen deficiency is vital to appropriately counsel and treat these patients. Prompt initiation of hormone therapy is critical to control the unsolicited menopausal symptoms that many women experience and to prevent long-term health complications. Despite ongoing efforts at improving our understanding of the mechanisms involved, any advancement in the field in recent decades has been modest at best and researchers remain thwarted by the complexity and heterogeneity of the underpinnings of this entity. In contrast, the practice of clinical medicine has made meaningful strides in providing assurance to the women with premature ovarian insufficiency that their quality of life as well as long-term health can be optimized through timely intervention. Ongoing research is clearly needed to allow pre-emptive identification of the at-risk population and to identify mechanisms that if addressed in a timely manner, can prolong ovarian function and physiology. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> premature ovarian insufficiency, POI, ovarian physiology, ovarian sex hormones </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Lubna Pal (<a href="mailto:lubna.pal@yale.edu">lubna.pal@yale.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Lubna Pal </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Saioa Torrealday and Pinar H. Kodaman declare that they have no competing interests. Lubna Pal is an advisory board member for AMAG Pharmaceuticals and a consultant for GLG. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Torrealday S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Torrealday S, Kodaman P and Pal L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2069 (<a href="https://doi.org/10.12688/f1000research.11948.1" target=_blank>https://doi.org/10.12688/f1000research.11948.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2069 (<a href="https://doi.org/10.12688/f1000research.11948.1" target=_blank>https://doi.org/10.12688/f1000research.11948.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Nov 2017, <b>6</b>(F1000 Faculty Rev):2069 (<a href="https://doi.org/10.12688/f1000research.11948.1" target=_blank>https://doi.org/10.12688/f1000research.11948.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e174>Introduction</h2><p class="" id=d39351e177>Premature ovarian insufficiency (POI), previously referred to as ovarian failure, is characterized by an accelerated truncation of ovarian physiology, chronologically well in advance of the timeline destined for the typical female <i>Sapiens</i>. Attrition in the number of residual ovarian follicles and ensuing deficiency in ovarian sex hormones are hallmarks of POI, thus rendering a woman subfertile and estrogen-deficient years, even decades, prior to the normal age of menopause. Subtleties in clinical presentation and a relative lack of population awareness surrounding this condition can lead to a delay in diagnosis and subsequent treatment. Beyond the psychological burden that this diagnosis consistently inflicts, health and well-being of women with POI are sensitive to any delay in the diagnosis and rely on timely initiation of hormone therapy (HT). Without prompt and adequate HT, women may develop severe symptoms and long-term health consequences of estrogen deficiency. One aspect of the confusion among both population and providers stems from the various nomenclatures used to reference this condition. The terms POI, premature menopause, and premature ovarian failure (POF) are synonymous and often are used interchangeably in the literature. Given the continuum of impaired ovarian function and the negative connotation of the word failure, the preferred term is POI. In order to remain consistent with recent recommendations for the nomenclature, the term POI will be used in this review.</p><p class="" id=d39351e183>To better understand the mechanisms underlying early ovarian dysfunction, it is prudent, depending on its mode of onset, to perceive POI as either spontaneous or consequent to a recognized insult such as following surgery (that is, bilateral oophorectomy) or following chemotherapy or radiation exposure. Although the two categories have a similar endpoint of premature and drastic attrition in the ovarian reserve and a paucity of circulating sex hormones, the onset varies between the two as often spontaneous POI is insidious in presentation and delay in diagnosis is common. In contrast, iatrogenic POI is almost always anticipated by both the patient and managing clinicians, and interventions to mitigate symptoms and harness the long-term health risks consequent to the hypoestrogenemia are initiated earlier in the process.</p><p class="" id=d39351e186>Evidence of hypergonadotrophic hypogonadism in the setting of amenorrhea (primary or secondary) in any woman younger than 40 years clinches the diagnosis of POI; depending on the trajectory of ovarian decline and pace of events, symptoms of hypoestrogenism may or may not dominate the clinical picture. This review will focus on the recent advances in the evaluation and management of POI with the goal of improving preparedness of health-care providers in ensuring optimal care for women afflicted by this complex yet common entity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e192>Clinical presentation</h2><p class="" id=d39351e195>The spectrum of symptomatology of POI is highly variable; symptoms can include manifestations of hypoestrogenism as well as additional features that may reflect unique signs of the underlying disorder that is causative of POI (<a href="#T1">Table 1</a>). For some women, the first indictor of ovarian insufficiency is reflected by new-onset menstrual irregularities that can range from infrequent to even too frequent menses before amenorrhea eventually sets in. Primary amenorrhea may be the presenting symptom in up to 10% of cases of POI; however, in the vast majority of women diagnosed with POI, menses commence and linger for varying lengths of time following normal pubertal development<sup><a href="#ref-1">1</a></sup>. Loss of regular menses for three consecutive months in an otherwise healthy and non-pregnant woman warrants further investigation, and POI should be considered among the differential diagnoses. For other women, distressing menopausal symptoms reflecting an estrogen-deficient state, such as hot flashes, dyspareunia, sleep disturbances, decreased libido, or vaginal dryness, may be the motivation for an initial medical consultation. Notable, however, is that women with primary amenorrhea may never experience menopausal symptoms; specifically, symptoms of hypoestrogenism are rare in those who were never exposed to estrogen. Furthermore, for some women, diagnosis of POI may be discovered only during evaluation for infertility.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Clinical presentation of premature ovarian insufficiency.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39351e216 class=n-a></a><tbody><a name=d39351e218 class=n-a></a><tr><a name=d39351e220 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e221 class=n-a></a>Menstrual abnormalities<br class=br>Missed cycles leading to amenorrhea<br class=br>Sudden onset of secondary amenorrhea<br class=br>Primary amenorrhea</td></tr><tr><a name=d39351e230 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e231 class=n-a></a>Subfertility/infertility</td></tr><tr><a name=d39351e234 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e235 class=n-a></a>Menopausal symptoms (hot flashes, vaginal dryness, and sleep<br class=br>disturbances)</td></tr><tr><a name=d39351e240 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e241 class=n-a></a>Changes in skin pigmentation<br class=br>Vitiligo (autoimmune)<br class=br>Hyperpigmentation-adrenal insufficiency (autoimmune)</td></tr><tr><a name=d39351e248 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e249 class=n-a></a>Hair loss/alopecia (autoimmune)</td></tr><tr><a name=d39351e253 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e254 class=n-a></a>Goiter (autoimmune)</td></tr><tr><a name=d39351e257 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e258 class=n-a></a>Fatigue</td></tr><tr><a name=d39351e261 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e262 class=n-a></a>Anxiety/Depression</td></tr></tbody></table></div><div class=section><a name=d39351e268 class=n-a></a><h3 class=section-title>Induced, often iatrogenic, premature ovarian insufficiency</h3><p class="" id=d39351e273>Bilateral oophorectomy occurs most commonly at the time of hysterectomy for both benign and malignant indications (<a href="#T2">Table 2</a>). Since most hysterectomies occur between 35 and 45 years of age, surgical POI is the leading cause of hormone deficiency in pre-menopausal women<sup><a href="#ref-2">2</a></sup>. Although the importance of ovarian preservation has received more attention in recent years, more than 200,000 women still undergo bilateral oophorectomy each year in the US<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Similarly, as more women are surviving malignancies treated with gonadotoxic chemotherapy or radiation, the incidence of iatrogenic POI is on the rise (<a href="#T2">Table 2</a>)<sup><a href="#ref-5">5</a></sup>. The degree of ovarian impairment is dependent on the womans age at the time of insult, type of gonadotoxic agent used, and the dose of chemotherapy or radiation used (<a href="#T3">Table 3</a>)<sup><a href="#ref-6">6</a><a href="#ref-10">10</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Causes of premature ovarian insufficiency.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39351e319 class=n-a></a><thead><a name=d39351e321 class=n-a></a><tr><a name=d39351e323 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d39351e325 class=n-a></a>Spontaneous</th></tr></thead><tbody><a name=d39351e330 class=n-a></a><tr><a name=d39351e332 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e333 class=n-a></a>&nbsp;&nbsp;&nbsp;<i>Idiopathic</i><br class=br>&nbsp;&nbsp;&nbsp;<i>Genetic</i><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Turner syndrome (45XO) or mosaic Turner (45X/46XX)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trisomy X (47XXX or mosaic)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fragile X premutation<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Galactosemia (galactose-1-phosphate uridyltransferase deficiency)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Autoimmune polyglandular syndrome (types 1 and 2)<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Follicle-stimulating hormone receptor mutations<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17-hydroxylase deficiency<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aromatase deficiency<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blepharophimosis, ptosis, epicanthus inversus syndrome<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bloom syndrome<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ataxia telangiectasia<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fanconi anemia<br class=br>&nbsp;&nbsp;&nbsp;<i>Autoimmune</i><br class=br>&nbsp;&nbsp;&nbsp;<i>Infections</i><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mumps oophoritis<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tuberculosis, malaria, cytomegalovirus, varicella, and shigella</td></tr><tr><a name=d39351e381 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d39351e383 class=n-a></a>Induced</th></tr><tr><a name=d39351e387 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e389 class=n-a></a>&nbsp;&nbsp;&nbsp;Bilateral oophorectomy, bilateral ovarian cystectomies<br class=br>&nbsp;&nbsp;&nbsp;Chemotherapy-primarily, alkylating agents and anthracyclines<br class=br>&nbsp;&nbsp;&nbsp;Radiation-external beam or intracavitary<br class=br>&nbsp;&nbsp;&nbsp;Environmental toxins<br class=br>&nbsp;&nbsp;&nbsp;Pelvic vessel embolization</td></tr></tbody></table></div><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Chemotherapy and radiation exposure and risk for premature ovarian insufficiency.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39351e414 class=n-a></a><thead><a name=d39351e416 class=n-a></a><tr><a name=d39351e418 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d39351e420 class=n-a></a>Chemotherapuetic agents and class<br class=br>known to cause gonadotoxicity and<br class=br>premature ovarian insufficiency risk<sup><a href="#ref-7">7</a></sup></th><th align=left colspan=1 rowspan=1 valign=top><a name=d39351e430 class=n-a></a>Radiation dose and age at exposure<br class=br>as determinants of permanent<br class=br>ovarian damage and premature<br class=br>ovarian insufficiency risk<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup></th></tr></thead><tbody><a name=d39351e447 class=n-a></a><tr><a name=d39351e449 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e450 class=n-a></a><b>Alkylating agent</b><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Nitrogen mustard<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Chlorambucil<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Cyclophosphamide<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Busulfan<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Melphalan<br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Dacarbazine</td><td colspan=1 rowspan=1 valign=top><a name=d39351e467 class=n-a></a>20.3 Gy at birth<br class=br>18.4 Gy at age 10 years<br class=br>16.5 Gy at age 20 years<br class=br>14.3 Gy at age 30 years<br class=br>6.0 Gy at age 40 or more years</td></tr><tr><a name=d39351e478 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e479 class=n-a></a><b>Anthracycline</b><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Doxorubicin</td><td colspan=1 rowspan=1><a name=d39351e485 class=n-a></a></td></tr><tr><a name=d39351e487 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e488 class=n-a></a><b>Substituted hydrazine</b><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;Procarbazine</td><td colspan=1 rowspan=1><a name=d39351e494 class=n-a></a></td></tr></tbody></table></div></div><div class=section><a name=d39351e500 class=n-a></a><h3 class=section-title>Spontaneous premature ovarian insufficiency</h3><p class="" id=d39351e505>This condition was first recognized in the 1930s when young women with amenorrhea were discovered to have elevated urinary gonadotropins. It was not until the 1940s that an association was made between the presence of high urinary gonadotropin levels and the classic histologic changes seen in the ovaries of menopausal women<sup><a href="#ref-11">11</a></sup>. In the ensuing decades, much has been learnt about the pathophysiology, along with the discovery of interventions that have been transformative in allowing women with POI to lead relatively normal and fulfilling lives.</p><p class="" id=d39351e512>The trajectory of attrition in the ovarian complement of gametes is at play well before the birth of a female infant, and this natural process of follicular atresia continues throughout the reproductive life span until menopause. However, when this nadir in the ovarian follicle complement is attained prior to the age of 40, it is considered premature given that it is 2 standard deviations from the mean estimated age of menopause (50  4 years) seen in the reference population<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d39351e519>A number of mechanisms can impact on the pace as well as the magnitude of progressive ovarian follicular atresia that characterizes human female gonadal physiology from early <i>in utero</i> existence up until menopause. Early ovarian senescence may reflect just an inherently small pool of ovarian reserve or quantity of primordial follicles that a woman is endowed with at the time of gametogenesis. Alternatively, POI may be the result of an accelerated destruction of oocyte complement because of a complex spectrum of disorders with genetic, autoimmune, or toxic underpinnings (<a href="#T2">Table 2</a> and <a href="#T3">Table 3</a>)<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>. Spontaneous POI is not an uncommon condition; it is estimated that approximately 0.3% to 1.1% of reproductive-age women experience menopause prematurely<sup><a href="#ref-15">15</a></sup>. Among women younger than 40, the incidence of POI steadily increases with advancing age. POI is recognized in 0.01% of women younger than 20, 0.1% younger than 30, and about 1% of woman younger than 40<sup><a href="#ref-16">16</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e551>Diagnosis</h2><p class="" id=d39351e554>As mentioned earlier, evidence of hypergonadotrophic hypogonadism in the setting of amenorrhea (primary or secondary) in any woman younger than 40 years is consistent with a diagnosis of POI. It is important to appreciate that unlike women with menopause, which marks an irreversible state of ovarian senescence, women with POI retain some degree ovarian function. Thus, fluctuations in ovarian hormones as well as sporadic spontaneous ovulations can be encountered in a small proportion of women with POI, adding complexity to the clinical picture.</p><p class="" id=d39351e557>A thorough review of medical and family history can provide some insight and guide providers in the process of arriving at a timely and correct diagnosis. Particular attention must be paid to the chronology of events, personal exposures, and family history. A detailed menstrual history that inquires about age of menarche, as well as both frequency and pattern of menses, is useful to determine any menstrual alteration early in the course of events. Medical conditions, medications prescribed, or previous gonadotoxic exposures should be noted since these can directly impact ovarian reserve and function. Of importance, documentation of any endocrinopathies (such as type 1 diabetes mellitus and hypothyroidism associated with Hashimotos thyroiditis) should be noted since it is not uncommon for these conditions to be seen in patients with POI. Although tobacco exposure (active as well as passive) has been associated with early menopause and is a recognized detriment to ovarian biology, its relevance for the causation of POI remains unclear<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>. Information on maternal age at menopause and family history of POI in first- or second-degree relatives may be pertinent, as can a history of mental retardation (particularly so in the male progeny), recurrent pregnancy loss, and history of any known autoimmune or genetic disorders in family members. A thorough review of systems should enquire about symptoms of fatigue and weight fluctuations and focus on, among other things, any involvement of the musculoskeletal and integumentary systems.</p><p class="" id=d39351e567>Physical examination should focus on stigmata of any underlying disorder (for example, skin depigmentation or hyperpigmentation may reflect underlying autoimmune disorder, as can evidence of a goiter) and on evidence of hypoestrogenism (<a href="#T1">Table 1</a>). Although examination is typically unremarkable in the majority of cases of POI, it may reveal evidence of estrogen deficiency marked by lack of or delayed secondary sex characteristics (when POI occurs prior to onset of puberty) or features of genital atrophy. During examination, providers should also look for stigmata that could point to underlying disorder causative of POI, such as cutaneous signs suggestive of an autoimmune conditions or phenotypic hallmarks of a chromosomal disorder (for example, short height, cubitus valgus, and dorsal cervical fat pad are all suggestive of Turner syndrome)<sup><a href="#ref-19">19</a></sup>. While signs and symptoms can be suggestive of POI, the diagnosis requires biochemical evidence of hypergonadotropic hypogonadism. Elevated serum follicle-stimulating hormone (FSH) levels (&gt;25 IU/L) on two separate occasions at least one month apart, with concomitant low estradiol (E2) levels (&lt;50 pg/mL), and amenorrhea for at least 4 months in women younger than 40 years of age are collectively required to establish a diagnosis of POI<sup><a href="#ref-18">18</a>,<a href="#ref-20">20</a></sup>. Additional laboratory tests can reinforce this impression and at times identify abnormalities that can point to an underlying mechanism (or mechanisms) for POI (<a href="#T4">Table 4</a>). Markedly low to undetectable serum levels of anti-mullerian hormone (AMH) in the setting of elevated FSH and suppressed E2 levels reaffirm the impression of POI<sup><a href="#ref-21">21</a></sup>. AMH may be particularly beneficial early in the phase of menstrual irregularity since the timing of analysis is independent of timing in a menstrual cycle, whereas FSH levels can fluctuate throughout the cycle and give a false sense of reassurance. A pelvic ultrasound, preferably using a transvaginal approach, can further confirm concerns for ovarian compromise. In appropriate clinical settings, evidence of a thin endometrial echo (&lt;4 mm), small ovarian volumes, and low antral follicle counts (&lt;5) are all consistent with a picture of POI; however, radiological imaging is not essential to establish the diagnosis.</p><div class="table-wrap panel clearfix"><a name=T4 class=n-a></a><div class=caption><h3>Table 4. Diagnostic considerations in evaluation of primary ovarian insufficiency.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d39351e602 class=n-a></a><thead><a name=d39351e604 class=n-a></a><tr><a name=d39351e606 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d39351e608 class=n-a></a>Laboratory tests</th><th align=left colspan=1 rowspan=1><a name=d39351e611 class=n-a></a>Rationale</th></tr></thead><tbody><a name=d39351e616 class=n-a></a><tr><a name=d39351e618 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e619 class=n-a></a>Human Chorionic gonadotropins</td><td colspan=1 rowspan=1 valign=top><a name=d39351e622 class=n-a></a>Exclude pregnancy</td></tr><tr><a name=d39351e625 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e626 class=n-a></a>Follicle-stimulating hormone<br class=br>Estradiol</td><td colspan=1 rowspan=1 valign=top><a name=d39351e631 class=n-a></a>Assess hypothalamic-pituitary-ovarian<br class=br>axis</td></tr><tr><a name=d39351e636 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e637 class=n-a></a>Anti-mullerian hormone</td><td colspan=1 rowspan=1 valign=top><a name=d39351e640 class=n-a></a>Assess ovarian reserve</td></tr><tr><a name=d39351e643 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e644 class=n-a></a>Karyotype, fragile X mental<br class=br>retardation 1 (FMR1) premutation</td><td colspan=1 rowspan=1 valign=top><a name=d39351e649 class=n-a></a>Evaluate for genetic etiology</td></tr><tr><a name=d39351e652 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e653 class=n-a></a>Thyroid-stimulating hormone<br class=br>Thyroid peroxidase antibody<br class=br>21-hydroxylase antibody</td><td colspan=1 rowspan=1 valign=top><a name=d39351e660 class=n-a></a>Evaluate for thyroid function<br class=br>Quantify risk for thyroid and adrenal<br class=br>dysfunction</td></tr><tr><a name=d39351e668 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d39351e669 class=n-a></a>Radiologic tests</th><th align=left colspan=1 rowspan=1><a name=d39351e672 class=n-a></a>Rationale</th></tr><tr><a name=d39351e675 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e676 class=n-a></a>Transvaginal ultrasound</td><td colspan=1 rowspan=1 valign=top><a name=d39351e679 class=n-a></a>Evaluate antral follicle count to assess<br class=br>ovarian reserve</td></tr><tr><a name=d39351e684 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d39351e685 class=n-a></a>Dual-energy x-ray absorptiometry scan</td><td colspan=1 rowspan=1 valign=top><a name=d39351e688 class=n-a></a>Assess bone density</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e697>Etiologies of premature ovarian insufficiency</h2><div class=section><a name=d39351e700 class=n-a></a><h3 class=section-title>Idiopathic</h3><p class="" id=d39351e705>Once POI is suspected, confirmation of this impression requires evidence of hypergonadotropic hypogonadism. A finite list of investigations is advised (<a href="#T4">Table 4</a>) with the goal of unmasking a possible etiology (which may have unique relevance for overall health) and quantifying short- and long-term risks (such as fracture risk due to low bone mass). Many underlying disorders may pose unique risks (for example, risk of aortic aneurism in a patient with Turner syndrome and an increased lifetime risk of autoimmune adrenal failure in patients with POI associated with autoimmune thyroid disease). The multiple etiologies of spontaneous POI that are recognized thus far include genetic, autoimmune, infectious, and idiopathic (<a href="#T2">Table 2</a>). Most cases of POI, accounting for over 90%, are idiopathic with no discernable cause<sup><a href="#ref-20">20</a></sup>.</p></div><div class=section><a name=d39351e719 class=n-a></a><h3 class=section-title>Genetic</h3><p class="" id=d39351e724>Genetic influences determine the size of the primordial follicle pool, impact on the rate of follicular atresia, and are a major determinant of eventual age at menopause. With the advent of more sophisticated genetic screening technologies, genetic etiologies for POI can account for about 20% to 25% of cases<sup><a href="#ref-22">22</a><a href="#ref-24">24</a></sup>. X-chromosome aberrations are the most commonly recognized genetic underpinnings for POI. Although the precise mechanism is not completely understood, it is thought that mutations on the loci of the long arm (q) of the X chromosome that regulate germ cell development and viability may be a contributing factor<sup><a href="#ref-25">25</a></sup>. Turner syndrome, which has a phenotype associated with complete or partial monosomy X and affects about 1 in 2,500 females, is the most common genetic condition resulting in POI<sup><a href="#ref-26">26</a></sup>. The most frequent chromosome constitution is 45 XO, or complete absence of one X chromosome. Women with 45XO have gonadal dysgenesis, and most cases have only streak ovaries composed of fibrous stromal tissue containing few or no ovum<sup><a href="#ref-19">19</a></sup>. About half of patients with Turner syndrome are mosaic, of which the most common chromosome composition is 45X/46XX (15%) while 46XXq or 46XXp deletions account for about 6%<sup><a href="#ref-19">19</a>,<a href="#ref-27">27</a></sup>. In patients with partial monosomy X, the exact karyotypic abnormality is relevant to determining the phenotype. Deletions on the short arm (p) of the X chromosome are associated with dysmorphic features such as short stature and congenital malformations, whereas partial or complete deletion of the q arm often manifests in gonadal dysfunction<sup><a href="#ref-27">27</a></sup>.</p><p class="" id=d39351e758>The fragile X mental retardation 1 (<i>FMR1</i>) gene that is located on the q arm of the X chromosome is of particular relevance in the context of POI<sup><a href="#ref-28">28</a></sup>. Fragile X syndrome, the most common cause of familial mental retardation, results from an inherited triplet repeat mutation in the <i>FMR1</i> gene. The normal number of CGG repeats in the untranslated region of the <i>FMR1</i> gene is less than 40. Repeat length between 55 and 200 is termed a premutation, and a length of greater than 200 repeats represents the full mutation<sup><a href="#ref-25">25</a></sup>. Interestingly, only those women with a premutation in the <i>FMR1</i> gene are at risk for developing POI, whereas those with either normal or full mutation are at no higher risk than the general population. Premutations of the <i>FMR1</i> gene are present in as many as 14% to 20% of women with familial POI and are found in up to 2% to 5% of women with isolated POI<sup><a href="#ref-29">29</a><a href="#ref-33">33</a></sup>. Owing to the increased risk of women with POI harboring the <i>FMR1</i> gene premutation, a family history of fragile X syndrome, unexplained mental retardation, tremor/ataxia syndrome, or having an affected child with developmental delays should be solicited. Furthermore, all women with POI who are seeking fertility should be screened for the FMR1 premutation given that spontaneous expansion of the trinucleotide repeat region can be transmitted to offspring in the unlikely event of successful conception, thus increasing the likelihood of fragile X syndrome in the progeny inheriting the full mutation. Male transmission of <i>FMR1</i> CGG repeats can also occur, although the transmission tends to be less stable than in women. In males, the CGG repeat can expand, contract, or remain unchanged, and the risk of expansion to full mutation is less frequent than in women<sup><a href="#ref-34">34</a></sup>.</p><p class="" id=d39351e802>Several less common genetic disorders have been associated with POI and should also be considered, particularly when there is a known family history of the disease traits (<a href="#T2">Table 2</a>). In the absence of any informative family history, autosomal genetic testing is not currently indicated in the workup of women with POI unless there is evidence or suspicion suggesting a specific mutation<sup><a href="#ref-18">18</a></sup>. With all genetic conditions, the patient should be referred to genetic counseling to fully comprehend the transmission pattern and full sequelae of the mutation.</p><p class="" id=d39351e812>In recent years, attention has focused on genes that are known to play a role in folliculogenesis and ovarian function. Oocyte-specific gene expression is necessary for primordial follicle formation and their subsequent differentiation into primary follicles. Several causative mutations in transcription factors, which regulate oocyte-specific genes, have been implicated in POI<sup><a href="#ref-35">35</a></sup>. Examples of POI transcription candidate genes include forkhead box L2 (<i>FOXL2</i>), nuclear receptor subfamily five group A member 1 (<i>NR5A1</i>), newborn ovary homeobox (<i>NOBOX</i>), and factor in germline alpha (<i>FIGLA</i>)<sup><a href="#ref-35">35</a><a href="#ref-38">38</a></sup>. Similarly, folliculogenesis growth factors, such as bone morphogenetic protein 15 (<i>BMP 15</i>), growth differentiation factor 9 (<i>GDF-9</i>), and inhibin alpha (<i>INHA</i>), which promote follicular maturation and folliculogenesis, are candidate genes. Heterozygous variants of these growth factors have also been associated with POI<sup><a href="#ref-35">35</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>.</p><p class="" id=d39351e859>Apart from the candidate gene approach, cytogenic and genetic linkage studies have been employed to discover a possible etiology of genetic POI. Cytogenic studies, primarily those affecting the X chromosome, have been identified and are closely associated with POI. Monosomy (X0) is the most common, but deletions, duplications, and translocations on the X chromosome have also been detected, primarily within two main loci named <i>POF1</i> and <i>POF2</i>, respectively<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. A second strategy has been to use genetic linkage in combination with positional cloning, a technique most advantageous for monogenic disease<sup><a href="#ref-41">41</a></sup>. Using this technique, genes encoding the gonadotropin receptors, follicle-stimulating hormone receptor (<i>FSHR</i>) and luteinizing hormone choriogonadotropin receptor (<i>LHCGR</i>), have been shown to harbor mutations, which results in the POI phenotype. FSH, secreted by the pituitary gland, is vital for the follicular recruitment and growth. Familial studies have shown that mutations in the <i>FSHR</i> gene, albeit rare, are associated with amenorrhea and ovarian dysfunction<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. The concern with this technique is that the majority of idiopathic POI cases are sporadic; thus, the utility of genetic linkage is nominal.</p><p class="" id=d39351e896>In efforts to detect novel POI genes, array comparative genomic hybridization (CGH) and genome-wide association studies (GWASs) have been used. With array CGH, reference DNA segments and affected DNA segments are labeled using different fluorochromes. The two samples are subsequently co-hybridized to induce competition and then compared with a given DNA sequence through an array. With this technique, the gain or loss of chromosomes or chromosomal regions, also referred to as copy number variations, between the two groups can be detected<sup><a href="#ref-45">45</a></sup>. Any disparity is examined to see whether the affected region has a role in ovarian pathophysiology or reproduction, thus introducing a potential candidate gene. With this modality, several regions of potential candidate genes have been identified; however, no causative mutation has been found<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d39351e907>More recently, genotyping via GWASs and genome-wide sequencing via next-generation sequencing (NGS) have been applied in efforts to identify genetic variations across the entire human genome that are associated with POI. GWAS and NGS allow assessment of the entire human genome with very detailed resolution and against numerous unrelated individuals<sup><a href="#ref-35">35</a></sup>. This evaluation is achieved by using single-nucleotide polymorphisms (SNPs), the most common genetic variations in the human genome, in patients with POI versus unaffected controls<sup><a href="#ref-35">35</a></sup>. A single nucleotide difference between two homologous chromosomes is considered polymorphic if both of these differences are found in at least 1% of the chromosomes in interbreeding populations<sup><a href="#ref-35">35</a></sup>. SNPs are then used as genetic markers in identifying genetic variants, which can be done either in familial cases or in a large cohort of patients. Although the application of GWASs in POI research has accelerated the identification of novel candidate genes and genetic risk factors, it has not identified any genes that have a significant role in the development of POI. There are only a limited number of GWASs that have been conducted on patients with POI, and the population size has been relatively limited.</p><p class="" id=d39351e922>Since one of the limitations of GWASs is the use of traditional Sanger sequencing, which can analyze only 700 base pairs per reaction, the use of NGS has proven to be a powerful tool to identify novel genes<sup><a href="#ref-46">46</a></sup>. NGS is a high-throughput DNA sequencing technique that can analyze millions of base pairs across the entire exome or genome in a single reaction<sup><a href="#ref-47">47</a></sup>. Thus far, the studies of POI using NGS have been limited to primarily inherited POI within families<sup><a href="#ref-46">46</a>,<a href="#ref-48">48</a><a href="#ref-50">50</a></sup>. These studies detected numerous pathogenic variants in genes associated with the following DNA repair pathways, hormone signaling, genomic instability, immune function, and gonadal development<sup><a href="#ref-50">50</a></sup>. For example, with whole-exome sequencing, an analysis of a consanguineous Palestinian family with POI revealed a onebase pair deletion in the stromal antigen 3 (<i>STAG3</i>) gene<sup><a href="#ref-47">47</a></sup>. <i>STAG3</i> encodes a meiosis-specific subunit of the cohesin ring, which ensures correct sister chromatid cohesion. Murine studies of the <i>STAG3</i> knockout supported the POI phenotype<sup><a href="#ref-48">48</a></sup>. As evident by the myriad of gene variants identified, without any clear frontrunner, the role that each variant plays in this complex disease is uncertain<sup><a href="#ref-50">50</a></sup>.</p><p class="" id=d39351e969>Lastly, the analysis of microRNAs (miRNAs) has been applied to POI research. miRNAs are small non-coding single-stranded RNA molecules, approximately 1825 nucleotides in size, which are involved in post-translational gene regulations and RNA silencing<sup><a href="#ref-35">35</a>,<a href="#ref-51">51</a></sup>. Although most studies looking at the role of miRNA in POI have been performed in murine models, there have been limited human studies evaluating miRNA within small cohorts of patients with POI<sup><a href="#ref-52">52</a></sup>. The first study was performed on three patients with POI and revealed an upregulated miRNA, mir-23a, which is shown to promote granulosa cell apoptosis<sup><a href="#ref-53">53</a></sup>. A larger study, in which Chinese women with POI were compared with controls, found 22 upregulated and 29 downregulated miRNAs within the affected subgroup. Upon further evaluation, attention was turned to mir-22-3p because of its regulation of pituitary FSH secretion. These few studies show that miRNA can affect ovarian function and folliculogenesis<sup><a href="#ref-54">54</a></sup>. As with all of the previous modalities discussed, larger sample size and evaluation within different ethnicities are indicated to determine the role that miRNA plays in POI.</p><p class="" id=d39351e991>Although numerous sequencing projects have involved the discovery of causative and candidate genes, the coding mutations found can explain only a minority of cases. Over 50 mutations have been validated in several genes (that is, <i>FSHR</i>, <i>LHCGR</i>, <i>NR5A1</i>, <i>NOBOX</i>, <i>FOXL2</i>, <i>FIGLA</i>, <i>BMP15</i>, <i>NANOS3</i>, and <i>STAG3</i>) via function assays as causative of idiopathic POI, while many other genes can be implicated<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a>,<a href="#ref-40">40</a>,<a href="#ref-43">43</a>,<a href="#ref-46">46</a>,<a href="#ref-48">48</a>,<a href="#ref-50">50</a>,<a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. This further supports the notion that POI is a heterogeneous genetic condition that involves the interplay of various genetic alterations and environmental factors, which remain unidentified. Since genes are identified on the basis of statistical significance and not necessarily biological relevance, often little is known about the physiological function of the identified variants. Clearly, more studies using larger cohorts to confirm their relevance and validity are needed.</p></div><div class=section><a name=d39351e1052 class=n-a></a><h3 class=section-title>Autoimmunity</h3><p class="" id=d39351e1057>More than 20% of women with POI will manifest more than one autoimmune condition<sup><a href="#ref-57">57</a></sup>. Autoimmune disorders of the thyroid gland (Graves or Hashimotos disease), seen in 20% to 30% of cases, are the most common autoimmune manifestations associated with POI<sup><a href="#ref-58">58</a><a href="#ref-60">60</a></sup>. Autoimmune adrenal failure (Addisons disease) is the second most common autoimmune disorder associated with POI and has the most severe health implications if undetected; it is seen in 3% of women with POI. Less frequently encountered is type I diabetes mellitus at 2.5%<sup><a href="#ref-60">60</a></sup>. Screening for anti-adrenal antibodies (specifically, anti-21-hydroxylase-Ab) and thyroid antibodies (thyroid peroxidase and, less commonly, thyroglobulin-Ab) is recommended in women with an unknown etiology for POI or if an autoimmune etiology is suspected<sup><a href="#ref-18">18</a></sup>. Respective end-organ function should be performed in women with POI given the high incidence of thyroid and adrenal disorders in this subset of women<sup><a href="#ref-18">18</a>,<a href="#ref-61">61</a></sup>. Yearly surveillance of thyroid-stimulating hormone levels should be undertaken in those positive for thyroid antibodies. Similarly, assessment of adrenal function using the adrenocorticotropic hormone (ACTH) stimulation test should be assumed in those testing positive for anti-adrenal antibodies. To perform this provocative test, a baseline level of cortisol is obtained prior to administration of a small dose of ACTH (typically synthetic cosyntropin [1 g] or an analogous corticotropic agent). The cortisol level produced by the adrenals in response to the ACTH bolus is measured at 30 and 60 minutes and subsequently compared with baseline levels. Cortisol levels should be more than 18 to 20 g/dL in response to the ACTH stimulation; however, if the cortisol levels remain low, primary adrenal insufficiency is implied. If thyroid and adrenal antibodies are initially negative, there is no indication for repeat testing on a routine basis<sup><a href="#ref-18">18</a></sup>. However, should signs or symptoms develop at a future date, a low threshold should be maintained to repeat screening for the suspected endocrinopathy<sup><a href="#ref-18">18</a></sup>.</p><p class="" id=d39351e1095>Circulating anti-ovarian antibodies are commonly detected in women with POI with evidence of other autoimmune disorders, and different studies have reported detection rates ranging from 10% to 69% in women with POI<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. However, despite this association, testing for anti-ovarian antibodies is of poor prognostic relevance and interpretation is highly variable. Therefore, anti-ovarian antibody testing is not recommended in the evaluation of women with POI.</p></div><div class=section><a name=d39351e1106 class=n-a></a><h3 class=section-title>Infections</h3><p class="" id=d39351e1111>Infectious etiologies have been implicated as a cause of POI, but the true incidence of post-infectious-oophoritis ovarian failure is uncertain. A variety of infections (viral and bacterial), including mumps oophoritis, tuberculosis, malaria, varicella, cytomegalovirus, and shigella, have been associated with POI<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>. In the majority of cases, once remission of the infectious insult is attained, normal ovarian function ensues<sup><a href="#ref-65">65</a></sup>. An infectious etiology should be considered if history relates symptomatology to a potential infectious exposure (that is, travel or sick contact). However, there is no indication to screen for infectious etiologies in a woman with POI without noted risk factors<sup><a href="#ref-18">18</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e1133>Sequelae and management of premature ovarian insufficiency</h2><div class=section><a name=d39351e1136 class=n-a></a><h3 class=section-title>Menopausal symptoms</h3><p class="" id=d39351e1141>Women with POI are susceptible to the gamut of symptoms experienced by the chronologically older cohorts approaching and going through menopause, including the classic menopausal symptoms of hot flashes, night sweats, sleep disturbances, mood instability, and issues of sexuality resulting from vaginal dryness, dyspareunia, and decreased libido. These symptoms can be particularly profound in cases of iatrogenic POI, and severity of bother is often so great that it significantly impacts a womans quality of life, psychological well-being, and intimate relationships. Menopausal symptoms in patients with POI are consequent to the premature decline in ovarian follicle number and a dysfunction of the residual follicles with resulting hypoestrogenemia and, to a lesser extent, a decline in ovarian testosterone. Adequate systemic estrogen replacement is critical for symptom control, whereas local estrogen may be required for addressing focal symptoms such as dyspareunia or other genito-urinary symptoms<sup><a href="#ref-1">1</a></sup>. Testosterone supplementation as an adjunct to systemic estrogen therapy may be of particular benefit for addressing issues of decreased libido in women following iatrogenic POI, although long-term efficacy and safety of androgens in menopause management remain uncertain<sup><a href="#ref-18">18</a></sup>.</p></div><div class=section><a name=d39351e1153 class=n-a></a><h3 class=section-title>Cardiovascular health</h3><p class="" id=d39351e1158>Women with untreated POI have a decreased life expectancy, largely due to cardiovascular morbidity and stroke<sup><a href="#ref-18">18</a>,<a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Compared with age-matched controls, women with POI had reduced vascular endothelial function, which is an early precursor to atherosclerosis<sup><a href="#ref-68">68</a></sup>. The use of HT for 6 months in this cohort of women significantly improved endothelial function<sup><a href="#ref-69">69</a></sup>. Estrogen has beneficial effects on cholesterol metabolism lessening atherosclerotic plaque formation and prevents coronary constriction via catecholamine modulation<sup><a href="#ref-70">70</a></sup>. Since estrogen dearth is the culprit, early initiation of HT following onset of menopause has been suggested as a cardio-protective strategy. Although randomized controlled trial data on cardiovascular benefits of HT remain equivocal, there is a consensus of opinion among experts in the field that benefits of initiation and continuation of HT in otherwise healthy women with POI until the average age of menopause (about 51 in the Caucasian population) far outweigh any purported risk<sup><a href="#ref-71">71</a></sup>. Despite lacking longitudinal outcome data in young women with POI, the cardio-protective benefits of HT are extrapolated from the data involving post-menopausal women<sup><a href="#ref-18">18</a>,<a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>. Moreover, it cannot be stressed enough how vital it is for women with POI to optimize modifiable risk factors (that is, diet, exercise, and smoking) to ensure cardiovascular health.</p></div><div class=section><a name=d39351e1199 class=n-a></a><h3 class=section-title>Bone health</h3><p class="" id=d39351e1204>Peak bone mass is attained by age 30 in women, and estrogen is fundamental to the bone accrual process<sup><a href="#ref-68">68</a></sup>. Deprivation of estrogen consequent to POI is a known fracture risk in later life<sup><a href="#ref-18">18</a>,<a href="#ref-74">74</a><a href="#ref-76">76</a></sup> and this risk can be mitigated with use of HT<sup><a href="#ref-68">68</a>,<a href="#ref-74">74</a></sup>. When compared with age-comparable menstruating women (mean age of 32 years), not only did those with POI have significantly lower bone mineral density (BMD), but 21% of those with POI had BMD z-score of less than 2.0, putting them at significant lifetime fracture risk<sup><a href="#ref-68">68</a>,<a href="#ref-75">75</a></sup>. Assessment of BMD may be useful and should be considered for women with POI; after the initial assessment, repeat BMD assessments can be deferred for those choosing to continue HT until the populations average age of menopause (51 years) or until the recommended age of 65 for all women<sup><a href="#ref-18">18</a></sup>. Evidence of low bone mass should be deemed an indication for prioritizing initiation of HT in any woman diagnosed with POI, and in these patients, serial monitoring of bone mass (within 2 to 5 years of initiating HT) is warranted. HT may have an even greater impact on women younger than 30 years of age, particularly if they have not yet attained peak bone mass<sup><a href="#ref-77">77</a></sup>. Lifestyle modifications such as weight-bearing exercises, optimization of dietary calcium intake and vitamin D status, and avoidance of cigarette use can all contribute to help preserve bone health<sup><a href="#ref-18">18</a></sup>. Declining BMD despite adequate HT dosing requires consideration of secondary causes of bone loss and may dictate consideration for use of non-hormonal anti-resorptive agents for fracture risk reduction<sup><a href="#ref-18">18</a></sup>. In the setting of low but stable BMD on HT regimen, pharmacologic agents such as bisphosphonates are generally avoided given the long half-life of these medications. The potential risk for fetal toxicity in future conceptions (either spontaneous or through use of donor eggs) is a concern in this young population<sup><a href="#ref-71">71</a></sup>. </p></div><div class=section><a name=d39351e1257 class=n-a></a><h3 class=section-title>Cognition</h3><p class="" id=d39351e1262>Premature deprivation of estrogen, such as following bilateral oophorectomy undertaken in pre-menopausal women, has been associated with neurocognitive decline. Women who underwent surgical menopause consequent to bilateral oophorectomy before natural menopause had an increased risk of cognitive decline and Alzheimers disease neuropathy, in particular neuritic plaque formation<sup><a href="#ref-2">2</a>,<a href="#ref-78">78</a></sup>. Of note, the earlier the age of surgical POI, the more rapid the cognitive decline<sup><a href="#ref-79">79</a></sup>. In contrast, women who were started on HT within 5 years of surgical menopause and continued treatment for 10 years showed decreased cognitive decline, suggesting protective effects of HT on neurocognition; notably, however, Alzheimers disease neuropathology was not reversed<sup><a href="#ref-2">2</a>,<a href="#ref-78">78</a></sup>. Appropriately designed studies are needed to understand whether women with POI are similarly at risk for neurocognitive decline as those rendered hypoestrogenemic following bilateral oophorectomy. Until then, the surgical POI data offer a logical benchmark to guide use of HT by women with POI until the age of natural menopause as a strategy to minimize risk of chronic disorders, including osteoporosis and premature cardiovascular disease, as well as for neurocognitive well-being<sup><a href="#ref-18">18</a>,<a href="#ref-80">80</a></sup>.</p></div><div class=section><a name=d39351e1292 class=n-a></a><h3 class=section-title>Emotional health</h3><p class="" id=d39351e1297>The diagnosis of POI is most often unexpected, creating psychological havoc for the afflicted young women. A realization of compromised fertility, fear of premature aging, and a perception of being different than their peers can all be emotionally overwhelming. Women with POI report reduced self-esteem, increased social anxiety and shyness, and symptoms of depression when compared with normal peers<sup><a href="#ref-81">81</a></sup>. Early psychological counseling should be advocated, and made easily accessible, for any woman stepping into menopause prematurely. Frequent visits with the womans multi-disciplinary team should be arranged to provide continued observation of her coping strategies and to address unmet needs.</p></div><div class=section><a name=d39351e1305 class=n-a></a><h3 class=section-title>Infertility</h3><p class="" id=d39351e1310>The rapid and unanticipated truncation in a womans reproductive life span is among the most distressful sequela of POI diagnosis, particularly for those women who have yet to embark on planning a family. Whereas fertility is markedly compromised, infertility in the setting of POI may not be absolute. Up to 25% of women with POI may spontaneously ovulate, and 5% to 10% will conceive and deliver after being diagnosed with POI<sup><a href="#ref-1">1</a>,<a href="#ref-82">82</a></sup>. Despite marked advances in the field of reproductive medicine in recent years, there are no interventions that can reliably improve residual ovarian reserve parameters or any treatment other than use of donor eggs which can improve conception rates in women with POI<sup><a href="#ref-18">18</a>,<a href="#ref-83">83</a></sup>. Women with POI should be reassured that spontaneous pregnancies from idiopathic POI do not show any higher obstetric morbidity or neonatal risk as compared with the general population<sup><a href="#ref-18">18</a></sup>. Conversely, those not interested in future fertility should be made aware that, despite the recognized reproductive compromise, spontaneous resumption of ovarian activity and thus unwanted conceptions can occur. Therefore, contraceptive strategies should be recommended in those women who wish to avoid pregnancy.</p><p class="" id=d39351e1331>Women with POI who are identified with chromosomal aberrations (such as balanced translocations or Turner mosaicism) or single-gene disorders such as <i>FMR1</i> premutation carrier state should undergo preconception counseling to better understand the risks to their progeny and of miscarriage in the event that successful conception is achieved; based on risk assessments, many may choose to consider use of donor eggs to maximize their chances for a healthy pregnancy. Those who are diagnosed with Turner syndrome (XO or mosaic XX/XO karyotype) hold unique pregnancy risks due to the high rate of cardiac abnormalities seen in this population and pregnancy-related escalation in risk for catastrophic cardiovascular events such as aortic dissection. Evaluations by a perinatologist and cardiologist are essential given that any evidence of aortic root abnormalities, common in this population, is a contraindication to pregnancy. Depending on the length of the CGG repeats, male children of women who harbor the FMR1 premutation may be at an increased risk of being affected by fragile X mental retardation. Use of <i>in vitro</i> fertilization (IVF) with preconception genetic diagnosing can minimize transgenerational transmission of identifiable genetic mutations in families that are deemed at an increased risk of passing genetic mutations to future progeny.</p><p class="" id=d39351e1340>For women with diagnosed or suspected POI for whom fertility is a priority, prompt referral to a reproductive endocrinologist is recommended. For those with established POI, while the opportunity for fertility preservation is missed, assisted conception by IVF using donor gametes or embryos provides the patient with the best option for biological parenting. Oocyte donation cycles generally result in high pregnancy rates given that the success rates are attributed to the age of the preselected and young oocyte donor. Alternatively, some couples prefer to pursue adoption to complete their families. All options should be offered to couples with a clear appreciation that this topic is sensitive and decisions should be individualized.</p><p class="" id=d39351e1343>In recent years, efforts have focused on pre-empting those who may be at risk for POI. In the select few women who can either anticipate the ovarian dysfunction (that is, prior to gonadotoxic treatments or surgery) or discern the diminished ovarian reserve prior to profound cessation of ovarian function, salvage of potential for future fertility may be possible. Cryopreservation of oocytes, embryos, or ovarian tissue is a strategy that can preserve future fertility in select women. Although embryo cryopreservation represents the gold-standard strategy for female fertility, this option is limited to women who are partnered or are willing to commit to donor sperm source. For the single woman, oocyte cryopreservation is a reasonable option, although the likelihood of a reasonable egg yield in the POI population or for those deemed at risk for POI is slim. Anecdotal success has been achieved with cryopreservation of ovarian cortical tissue followed by orthotopic autotransplant (graft into the pelvis); however, this procedure is still considered experimental. Notably, applicability of this technique in the POI population has not been studied and should be offered only at institutions with institutional review board oversight<sup><a href="#ref-84">84</a></sup>.</p><p class="" id=d39351e1351>For women anticipating receiving pelvic radiation for management of an underlying disorder, such as cervical cancer, where radiation-induced POI is almost inevitable, surgical transposition of the ovaries out of the pelvis can limit radiation exposure and may serve to preserve gonadal function. For women anticipating undergoing chemotherapy with gonadotoxic agents, other than the fertility preservation options of egg, embryo, or ovarian tissue cryopreservation, suppression of ovarian function pre-chemotherapy with use of gonadotropin-releasing hormone analogs is commonly employed. Efficacy data on the magnitude of fertility preservation achieved using this strategy, however, are conflicting. Until efficacy is clearly demonstrated, proven, and established, fertility preservation therapies should remain first-line options<sup><a href="#ref-85">85</a></sup>.</p><p class="" id=d39351e1358>An exciting area of research to improve gamete yield from ovarian tissue in women with POI has recently been reported that uses <i>in vitro</i> activation (IVA) followed by auto-transplantation of ovarian tissue. In women with POI one ovary was removed and IVA achieved through activation of the AKT pathway in the few dormant follicles that were found within the ovarian tissue. The ovary was re-transplanted and residual follicles were seen to be active in 6 of the 14 patients (43%), and following IVF with oocyte retrieval, a pregnancy was achieved<sup><a href="#ref-86">86</a><a href="#ref-88">88</a></sup>. More studies are needed to determine the efficacy of the IVA treatment protocol and whether this will be a useful tool in the future for women with POI.</p><p class="" id=d39351e1371>An area of research that has the potential for revolutionizing the course of POI is that of stem cell technology. Therapeutic potential of hematopoietic and mesenchymal stem cells in humans has progressed over recent years, and much effort has focused on establishing the existence of oogonial stem cells (OSCs), challenging the central dogma that women are born with a fixed number of oocytes that steadily declines until menopause is reached. Indeed, a number of investigators have now reported success in identifying OSCs in experimental models allowing postulation that mitotically active OSCs may also be present in human ovarian cortex<sup><a href="#ref-89">89</a><a href="#ref-93">93</a></sup>. OSCs have been detected in women and have been able to form oocyte-like structures in a xenotransplant model<sup><a href="#ref-92">92</a>,<a href="#ref-94">94</a></sup>; however, the physiological relevance of OSCs in human female remains unclear<sup><a href="#ref-91">91</a></sup>. OSC research is a primitive yet exciting area of research that has the potential to revolutionize reproductive medicine, particularly in women with POI or age-related ovarian decline. </p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e1397>Hormone treatment in the management of premature ovarian insufficiency</h2><p class="" id=d39351e1400>In the past two decades, the role of HT in menopause management has undergone stringent inquisitions, and practice of menopause management has undergone transformative changes driven by myriad of interpretations and misinterpretations of data from the Womens Health Initiative (WHI) hormone trials<sup><a href="#ref-95">95</a></sup>. Notably, the two seminal WHI hormone trials (estrogen alone for women who had previously undergone hysterectomy and estrogen plus progestin trial for those with intact uteri) were undertaken in an elderly and predominantly asymptomatic population of women who were at advanced stage of menopause. The studies were terminated prematurely because of concerns that potential benefit was exceeded by net harm, given the studies did not establish that HT offered cardiovascular benefit (primary endpoint). The fate of the WHI hormone trials was erroneously perceived by practitioners and patients alike as a judgment against safety and place of HT for all. That HT-related concerns observed in an aged and relatively asymptomatic population of menopausal women, who were well established in menopause (WHI population), were extrapolated and deemed applicable to the young and healthy, perimenopausal and early menopausal women (the vast majority of women, who are in need of HT to improve their quality of life) can only be deemed as a tragic misinterpretation of the then-existing data, which has caused a disservice to multitudes of symptomatic women. In recent years, driven as much by introspection and re-analyses of existing data as by reassurance offered by newer clinical trials, the pendulum of opinion and practice has shifted toward moderation and a commonsense approach to use of HT. Most importantly, a vociferous consensus exists in support of using HT in women with POI, both for symptom management and for mitigating burden from chronic disorders that are directly impacted by premature loss of estrogen (such as osteoporosis, cardiovascular, and neurocognitive disorders) and that have been previously highlighted in this review. The goal of HT in POI population is to mimic endogenous levels of sex hormones, which equates to a serum E2 level of about 100 pg/mL, and once initiated, HT should be continued until the age of natural menopause (average age of 51 years)<sup><a href="#ref-68">68</a></sup>. Despite the consensus and clarity in safety and recommendation for offering HT to women with POI, an assessment of HT use among this population revealed that more than 52% of women with POI never took HT, started HT years after the diagnosis was established, or discontinued HT before the age of 45 or that a combination of these was the case<sup><a href="#ref-68">68</a>,<a href="#ref-96">96</a></sup>. Untreated or inadequately treated women with POI must be perceived at an increased risk of long-term morbidity, which could have been averted if addressed in a timely manner proximate to time of diagnosis.</p><div class=section><a name=d39351e1418 class=n-a></a><h3 class=section-title>Post-pubertal premature ovarian insufficiency</h3><p class="" id=d39351e1423>Given the young age at time of ovarian insufficiency and symptom severity experienced by women with POI, this population often requires higher doses of systemic estrogen than is commonly used for managing symptoms in older menopausal women. In deciding on the choice of HT, consideration should be given to dose, route, and regimen; while estrogen alone is optimal for managing symptoms in women who have undergone hysterectomy, the addition of progestin must be incorporated to estrogen therapy in those with an intact uterus. Not only is the thromboembolic risk related to estrogen use suggested to be lessened with transdermal compared with oral route of administration, transdermal dosing is recognized to provide better sustained circulating levels of estradiol compared with oral intake and this itself may offer some advantage for symptom control. The typical starting formulation for women with POI includes transdermal estradiol in a daily dose of 100 g, oral estradiol in a dose of 1 to 2 mg/day, or conjugated estrogen at a dose of 0.625 to 1.25 mg daily. Patients must be advised to maintain a symptom chart, and hormone dose should be adjusted to achieve a level of symptom control that translates to an optimized quality of life.</p><p class="" id=d39351e1426>Oral combined hormonal contraceptives are an alternative for symptom management and may be psychologically preferred by some young and symptomatic women with POI. It should be noted that combined hormone contraceptives provide supratherapeutic levels of estrogen and progesterone given that the intent of the medication in normal, cycling woman is to suppress ovulation. Therefore, for women who are seeking potential for fertility and willing to avail the slim possibility of spontaneous ovulation, use of hormonal contraceptive regimen should be avoided. If this method is selected, it may be beneficial to avoid the hormone-free placebo week in efforts to minimize the likelihood of recrudescence of symptoms of hypoestrogenemia during the hormone-free window. It should be noted that, in women with POI, oral contraceptive pills are not as efficacious in preventing pregnancy and this is likely due to the persistent elevated serum gonadotropin levels detected within this subgroup. If contraception is desired, barrier contraceptive measures and intrauterine devices are recommended.</p><p class="" id=d39351e1429>In all women with a uterus, progesterone should be added to the estrogen regimen to minimize the untoward risk of endometrial hyperplasia or endometrial cancer, which is a recognized sequel to prolonged use of unopposed estrogen<sup><a href="#ref-97">97</a></sup>. Both natural progesterone and synthetic progestins are available in a wide array of formulations (oral tablets, vaginal creams/tablets, intramuscular injection, and intrauterine devices) and regimens (continuous and cyclic). Common formulations that are used for endometrial protection in HT users include medroxyprogesterone acetate 10 mg daily for 12 days each month and oral or vaginal micronized progesterone 100 mg daily or 200 mg daily for 10 to 12 days per month. To date, the only study evaluating HT in women with POI is the National Institutes of Health Intramural Research Program, which used transdermal E2 (100 g/day) with oral medroxyprogesterone acetate (10 mg/12 days), which was well tolerated<sup><a href="#ref-74">74</a></sup>. While there are some advantages to preferential use of micronized natural progesterone (reduced breast cancer risk in some studies and some benefit for improved sleep), the strongest evidence of endometrial protection is for oral cyclic medroxyprogesterone acetate<sup><a href="#ref-18">18</a></sup>. Although the efficacy of oral micronized progestin or progestin-containing intrauterine contraceptive devices to effectively induce endometrial decidualization has not been systematically evaluated as a component of HT for women with POI, these formulations are increasingly being incorporated in menopause management, and future trials should specifically explore their value for women with POI.</p></div><div class=section><a name=d39351e1445 class=n-a></a><h3 class=section-title>Prepubertal premature ovarian insufficiency</h3><p class="" id=d39351e1450>In some young women, onset of POI predates onset of puberty; overt stigmata of failure of ovarian estrogenization include lacking secondary sex characteristics (that is, thelarche), retarded skeletal growth, and primary amenorrhea. Although Turners syndrome (XO) is the prototype for prepubertal POI, any condition that results in complete ovarian failure during childhood (such as whole body radiation for bone marrow transplant) would have similar consequences. In keeping with pubertal physiology wherein a gradual escalation in circulating estrogens predates menarche by a few years, for a patient in whom POI strikes prior to puberty, the goal of HT is to achieve exposure to increasing estrogen levels in a progressive fashion over months, starting with very low doses of 17- estradiol. Typical regimens include 6.25 g/day of 17- estradiol transdermally or micronized oral estradiol 0.25 mg/day<sup><a href="#ref-18">18</a></sup>. The 17- estradiol is gradually increased every 3 to 6 months over the course of 2 years until an adult dose is reached or spontaneous menses ensues, at which point cyclic progesterone regimen is added to ensure endometrial protection similar to the one discussed under management of post-pubertal patients. Oral micronized progesterone 100 to 200 mg/day for 12 to 14 days is the most common regimen used<sup><a href="#ref-98">98</a></sup>. It should be noted that use of a hormone contraceptive formulation as HT strategy is to be avoided in these young girls until estrogen aloneinduced puberty has been completed as premature use of combined hormone regimens can result in tubular breast formation<sup><a href="#ref-26">26</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d39351e1469>Summary of current perspective and future goals</h2><p class="" id=d39351e1472>Despite the advances in our understanding of POI, the vast majority of cases remain idiopathic, and there is no clear etiology to explain the phenotype. Regardless of the etiology, POI is a state of estrogen deprivation that holds both short-term and life-long implications for health and for psychosocial well-being. The magnitude of ongoing research efforts as well as direction of some novel quests discussed in this review should offer hope for those afflicted as well as invigorate those who are engaged in caring for this unique population. While awaiting the blossoming of a promise that tissue-specific stem cell salvage and therapy may offer, timely initiation of HT and a multi-disciplinary approach must be recognized as cornerstones to effectively manage this complex entity to ensure that physical, psychological, and emotional challenges that result from POI diagnosis are met and short-term and long-term well-being of these young women is optimized.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d39351e1 class=n-a></a><h2 class=main-title id=d39636>Competing interests</h2><p class=metadata-entry><a name=d39351e111 class=n-a></a><p id=d39351e112> Saioa Torrealday and Pinar H. Kodaman declare that they have no competing interests. Lubna Pal is an advisory board member for AMAG Pharmaceuticals and a consultant for GLG.</p></p></div><div class=back-section><a name=d39351e1 class=n-a></a><h2 class=main-title id=d39638>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d39351e1479 class=n-a></a><h2 class=main-title id=d39351e1481>Acknowledgments</h2><p class="" id=d39351e1484>The opinions or assertions contained herein are the private views of the authors and are not to be construed as the official policy of the US Department of the Army, US Department of Defense, or the US Government.</p></div><div class=back-section><a name=d39351e1488 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d39968>References</h2><div class="section ref-list"><a name=d39351e1488 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d39351e1495 class=n-a></a>Rebar RW: Premature ovarian failure. <i>Obstet Gynecol.</i> 2009; <b>113</b>(6): 135563. <a target=xrefwindow id=d39351e1503 href="http://www.ncbi.nlm.nih.gov/pubmed/19461434">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1506 href="http://dx.doi.org/10.1097/AOG.0b013e3181a66843">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726900790"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e1515 class=n-a></a>Sarrel PM, Sullivan SD, Nelson LM: Hormone replacement therapy in young women with surgical primary ovarian insufficiency. <i>Fertil Steril.</i> 2016; <b>106</b>(7): 15807. <a target=xrefwindow id=d39351e1523 href="http://www.ncbi.nlm.nih.gov/pubmed/27793381">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1526 href="http://dx.doi.org/10.1016/j.fertnstert.2016.09.018">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1529 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5248494">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726900790">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d39351e1542 class=n-a></a>Asante A, Whiteman MK, Kulkarni A, <i> et al.</i>: Elective oophorectomy in the United States: trends and in-hospital complications, 19982006. <i>Obstet Gynecol.</i> 2010; <b>116</b>(5): 108895. <a target=xrefwindow id=d39351e1553 href="http://www.ncbi.nlm.nih.gov/pubmed/20966693">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1556 href="http://dx.doi.org/10.1097/AOG.0b013e3181f5ec9d">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d39351e1565 class=n-a></a>Wright JD, Herzog TJ, Tsui J, <i> et al.</i>: Nationwide trends in the performance of inpatient hysterectomy in the United States. <i>Obstet Gynecol.</i> 2013; <b>122</b>(2 Pt 1): 23341. <a target=xrefwindow id=d39351e1576 href="http://www.ncbi.nlm.nih.gov/pubmed/23969789">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1579 href="http://dx.doi.org/10.1097/AOG.0b013e318299a6cf">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1583 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3913114">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d39351e1592 class=n-a></a>National Institutes of Health, National Cancer Institute: Division of Cancer Survivorship. Access: April 16, 2017. <a target=xrefwindow id=d39351e1594 href="https://cancercontrol.cancer.gov/ocs/statistics/statistics.html">Reference Source</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d39351e1604 class=n-a></a>Sklar C: Maintenance of ovarian function and risk of premature menopause related to cancer treatment. <i>J Natl Cancer Inst Monographs.</i> 2005; <b>2005</b>(34): 257. <a target=xrefwindow id=d39351e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/15784817">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1615 href="http://dx.doi.org/10.1093/jncimonographs/lgi018">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d39351e1624 class=n-a></a>Shuster LT, Rhodes DJ, Gostout BS, <i> et al.</i>: Premature menopause or early menopause: long-term health consequences. <i>Maturitas.</i> 2010; <b>65</b>(2): 1616. <a target=xrefwindow id=d39351e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/19733988">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1638 href="http://dx.doi.org/10.1016/j.maturitas.2009.08.003">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1642 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2815011">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d39351e1651 class=n-a></a>Hyman JH, Tulandi T: Fertility preservation options after gonadotoxic chemotherapy. <i>Clin Med Insights Reprod Health.</i> 2013; <b>7</b>: 619. <a target=xrefwindow id=d39351e1659 href="http://www.ncbi.nlm.nih.gov/pubmed/24453520">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1662 href="http://dx.doi.org/10.4137/CMRH.S10848">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3888081">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d39351e1674 class=n-a></a>Wallace WH, Thomson AB, Saran F, <i> et al.</i>: Predicting age of ovarian failure after radiation to a field that includes the ovaries. <i>Int J Radiat Oncol Biol Phys.</i> 2005; <b>62</b>(3): 73844. <a target=xrefwindow id=d39351e1685 href="http://www.ncbi.nlm.nih.gov/pubmed/15936554">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1688 href="http://dx.doi.org/10.1016/j.ijrobp.2004.11.038">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d39351e1697 class=n-a></a>Ash P: The influence of radiation on fertility in man. <i>Br J Radiol.</i> 1980; <b>53</b>(628): 2718. <a target=xrefwindow id=d39351e1705 href="http://www.ncbi.nlm.nih.gov/pubmed/6991051">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1708 href="http://dx.doi.org/10.1259/0007-1285-53-628-271">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d39351e1717 class=n-a></a>Albright F, Smith PH, Fraser R: A SYNDROME CHARACTERIZED BY PRIMARY OVARIAN INSUFFICIENCY AND DECREASED STATURE. <i>Am J Med Sci.</i> 1942; <b>204</b>(5): 62548. <a target=xrefwindow id=d39351e1725 href="http://www.sid.ir/En/Journal/ViewPaper.aspx?ID=306588">Reference Source</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d39351e1735 class=n-a></a>van Noord PA, Dubas JS, Dorland M, <i> et al.</i>: Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. <i>Fertil Steril.</i> 1997; <b>68</b>(1): 95102. <a target=xrefwindow id=d39351e1746 href="http://www.ncbi.nlm.nih.gov/pubmed/9207591">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1749 href="http://dx.doi.org/10.1016/S0015-0282(97)81482-3">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d39351e1758 class=n-a></a>Welt CK: Primary ovarian insufficiency: a more accurate term for premature ovarian failure. <i>Clin Endocrinol (Oxf).</i> 2008; <b>68</b>(4): 499509. <a target=xrefwindow id=d39351e1766 href="http://www.ncbi.nlm.nih.gov/pubmed/17970776">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1769 href="http://dx.doi.org/10.1111/j.1365-2265.2007.03073.x">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d39351e1778 class=n-a></a>Kodaman PH: Early menopause: primary ovarian insufficiency and surgical menopause. <i>Semin Reprod Med.</i> 2010; <b>28</b>(5): 3609. <a target=xrefwindow id=d39351e1786 href="http://www.ncbi.nlm.nih.gov/pubmed/20845236">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1789 href="http://dx.doi.org/10.1055/s-0030-1262895">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d39351e1798 class=n-a></a>Luborsky JL, Meyer P, Sowers MF, <i> et al.</i>: Premature menopause in a multi-ethnic population study of the menopause transition. <i>Hum Reprod.</i> 2003; <b>18</b>(1): 199206. <a target=xrefwindow id=d39351e1809 href="http://www.ncbi.nlm.nih.gov/pubmed/12525467">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1812 href="http://dx.doi.org/10.1093/humrep/deg005">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d39351e1821 class=n-a></a>Coulam CB, Adamson SC, Annegers JF: Incidence of premature ovarian failure. <i>Obstet Gynecol.</i> 1986; <b>67</b>(4): 6046. <a target=xrefwindow id=d39351e1829 href="http://www.ncbi.nlm.nih.gov/pubmed/3960433">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1832 href="http://dx.doi.org/10.1097/00006254-198742030-00020">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d39351e1841 class=n-a></a>Schoenaker DA, Jackson CA, Rowlands JV, <i> et al.</i>: Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. <i>Int J Epidemiol.</i> 2014; <b>43</b>(5): 154262. <a target=xrefwindow id=d39351e1852 href="http://www.ncbi.nlm.nih.gov/pubmed/24771324">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1855 href="http://dx.doi.org/10.1093/ije/dyu094">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1859 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4190515">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726233786"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e1869 class=n-a></a>European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, <i> et al.</i>: ESHRE Guideline: management of women with premature ovarian insufficiency. <i>Hum Reprod.</i> 2016; <b>31</b>(5): 92637. <a target=xrefwindow id=d39351e1880 href="http://www.ncbi.nlm.nih.gov/pubmed/27008889">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1883 href="http://dx.doi.org/10.1093/humrep/dew027">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726233786">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d39351e1896 class=n-a></a>Abir R, Fisch B, Nahum R, <i> et al.</i>: Turner's syndrome and fertility: current status and possible putative prospects. <i>Hum Reprod Update.</i> 2001; <b>7</b>(6): 60310. <a target=xrefwindow id=d39351e1907 href="http://www.ncbi.nlm.nih.gov/pubmed/11727869">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1910 href="http://dx.doi.org/10.1093/humupd/7.6.603">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d39351e1919 class=n-a></a>Nelson LM: Clinical practice. Primary ovarian insufficiency. <i>N Engl J Med.</i> 2009; <b>360</b>(6): 60614. <a target=xrefwindow id=d39351e1927 href="http://www.ncbi.nlm.nih.gov/pubmed/19196677">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1930 href="http://dx.doi.org/10.1056/NEJMcp0808697">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1933 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2762081">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d39351e1942 class=n-a></a>Visser JA, Schipper I, Laven JS, <i> et al.</i>: Anti-Mllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. <i>Nat Rev Endocrinol.</i> 2012; <b>8</b>(6): 33141. <a target=xrefwindow id=d39351e1953 href="http://www.ncbi.nlm.nih.gov/pubmed/22231848">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1956 href="http://dx.doi.org/10.1038/nrendo.2011.224">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725699274"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e1965 class=n-a></a>Qin Y, Jiao X, Simpson JL, <i> et al.</i>: Genetics of primary ovarian insufficiency: new developments and opportunities. <i>Hum Reprod Update.</i> 2015; <b>21</b>(6): 787808. <a target=xrefwindow id=d39351e1976 href="http://www.ncbi.nlm.nih.gov/pubmed/26243799">PubMed Abstract </a> | <a target=xrefwindow id=d39351e1979 href="http://dx.doi.org/10.1093/humupd/dmv036">Publisher Full Text </a> | <a target=xrefwindow id=d39351e1983 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4594617">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725699274">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729207456"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e1996 class=n-a></a>Hernndez-Angeles C, Castelo-Branco C: Early menopause: A hazard to a woman's health. <i>Indian J Med Res.</i> 2016; <b>143</b>(4): 4207. <a target=xrefwindow id=d39351e2004 href="http://www.ncbi.nlm.nih.gov/pubmed/27377497">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2007 href="http://dx.doi.org/10.4103/0971-5916.184283">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2010 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4928547">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729207456">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d39351e2024 class=n-a></a>Fortuo C, Labarta E: Genetics of primary ovarian insufficiency: a review. <i>J Assist Reprod Genet.</i> 2014; <b>31</b>(12): 157385. <a target=xrefwindow id=d39351e2032 href="http://www.ncbi.nlm.nih.gov/pubmed/25227694">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2035 href="http://dx.doi.org/10.1007/s10815-014-0342-9">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2038 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4250468">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d39351e2047 class=n-a></a>Laml T, Preyer O, Umek W, <i> et al.</i>: Genetic disorders in premature ovarian failure. <i>Hum Reprod Update.</i> 2002; <b>8</b>(5): 48391. <a target=xrefwindow id=d39351e2058 href="http://www.ncbi.nlm.nih.gov/pubmed/12398227">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2061 href="http://dx.doi.org/10.1093/humupd/8.5.483">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d39351e2070 class=n-a></a>Bondy CA, Turner Syndrome Study Group: Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. <i>J Clin Endocrinol Metab.</i> 2007; <b>92</b>(1): 1025. <a target=xrefwindow id=d39351e2078 href="http://www.ncbi.nlm.nih.gov/pubmed/17047017">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2081 href="http://dx.doi.org/10.1210/jc.2006-1374">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d39351e2090 class=n-a></a>Thompson MW, McInnes RR, Willard HF: The sex chromosomes and their abnormalities. In Thompson MW, McInnes RR and Willard HF (eds). <i>Genetics in Medicine</i>. WB. Saunders, Philadelphia, 239243. </span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d39351e2102 class=n-a></a>Wittenberger MD, Hagerman RJ, Sherman SL, <i> et al.</i>: The FMR1 premutation and reproduction. <i>Fertil Steril.</i> 2007; <b>87</b>(3): 45665. <a target=xrefwindow id=d39351e2113 href="http://www.ncbi.nlm.nih.gov/pubmed/17074338">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2116 href="http://dx.doi.org/10.1016/j.fertnstert.2006.09.004">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d39351e2125 class=n-a></a>Beck-Peccoz P, Persani L: Premature ovarian failure. <i>Orphanet J Rare Dis.</i> 2006; <b>1</b>: 9. <a target=xrefwindow id=d39351e2133 href="http://www.ncbi.nlm.nih.gov/pubmed/16722528">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2136 href="http://dx.doi.org/10.1186/1750-1172-1-9">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1502130">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d39351e2149 class=n-a></a>Rafique S, Sterling EW, Nelson LM: A new approach to primary ovarian insufficiency. <i>Obstet Gynecol Clin North Am.</i> 2012; <b>39</b>(4): 56786. <a target=xrefwindow id=d39351e2157 href="http://www.ncbi.nlm.nih.gov/pubmed/23182561">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2160 href="http://dx.doi.org/10.1016/j.ogc.2012.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2163 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3727655">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d39351e2172 class=n-a></a>Murray A, Schoemaker MJ, Bennett CE, <i> et al.</i>: Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. <i>Genet Med.</i> 2014; <b>16</b>(1): 1924. <a target=xrefwindow id=d39351e2183 href="http://www.ncbi.nlm.nih.gov/pubmed/23703681">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2186 href="http://dx.doi.org/10.1038/gim.2013.64">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2190 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3914024">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d39351e2199 class=n-a></a>Sherman SL: Premature ovarian failure in the fragile X syndrome. <i>Am J Med Genet.</i> 2000; <b>97</b>(3): 18994. <a target=xrefwindow id=d39351e2207 href="http://www.ncbi.nlm.nih.gov/pubmed/11449487">PubMed Abstract </a> | <a target="xrefwindow" id="d39351e2210" href="http://dx.doi.org/10.1002/1096-8628(200023)97:3<189::AID-AJMG1036&gt;3.0.CO;2-J">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d39351e2219 class=n-a></a>Sullivan SD, Welt C, Sherman S: FMR1 and the continuum of primary ovarian insufficiency. <i>Semin Reprod Med.</i> 2011; <b>29</b>(4): 299307. <a target=xrefwindow id=d39351e2227 href="http://www.ncbi.nlm.nih.gov/pubmed/21969264">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2230 href="http://dx.doi.org/10.1055/s-0031-1280915">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727123803"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2239 class=n-a></a>Barasoain M, Barrenetxea G, Huerta I, <i> et al.</i>: Study of the Genetic Etiology of Primary Ovarian Insufficiency: FMR1 Gene. <i>Genes (Basel).</i> 2016; <b>7</b>(12): pii: E123. <a target=xrefwindow id=d39351e2250 href="http://www.ncbi.nlm.nih.gov/pubmed/27983607">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2253 href="http://dx.doi.org/10.3390/genes7120123">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2257 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5192499">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727123803">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725832588"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2270 class=n-a></a>Chapman C, Cree L, Shelling AN: The genetics of premature ovarian failure: current perspectives. <i>Int J Womens Health.</i> 2015; <b>7</b>: 799810. <a target=xrefwindow id=d39351e2278 href="http://www.ncbi.nlm.nih.gov/pubmed/26445561">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2281 href="http://dx.doi.org/10.2147/IJWH.S64024">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2284 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4590549">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725832588">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d39351e2298 class=n-a></a>Harris SE, Chand AL, Winship IM, <i> et al.</i>: Identification of novel mutations in FOXL2 associated with premature ovarian failure. <i>Mol Hum Reprod.</i> 2002; <b>8</b>(8): 72933. <a target=xrefwindow id=d39351e2309 href="http://www.ncbi.nlm.nih.gov/pubmed/12149404">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2312 href="http://dx.doi.org/10.1093/molehr/8.8.729">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d39351e2321 class=n-a></a>Qin Y, Choi Y, Zhao H, <i> et al.</i>: NOBOX homeobox mutation causes premature ovarian failure. <i>Am J Hum Genet.</i> 2007; <b>81</b>(3): 57681. <a target=xrefwindow id=d39351e2332 href="http://www.ncbi.nlm.nih.gov/pubmed/17701902">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2335 href="http://dx.doi.org/10.1086/519496">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1950834">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1161447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2348 class=n-a></a>Loureno D, Brauner R, Lin L, <i> et al.</i>: Mutations in <i>NR5A1</i> associated with ovarian insufficiency. <i>N Engl J Med.</i> 2009; <b>360</b>(12): 120010. <a target=xrefwindow id=d39351e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/19246354">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2366 href="http://dx.doi.org/10.1056/NEJMoa0806228">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2778147">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1161447">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d39351e2382 class=n-a></a>Rah H, Jeon YJ, Ko JJ, <i> et al.</i>: Association of inhibin  gene promoter polymorphisms with risk of idiopathic primary ovarian insufficiency in Korean women. <i>Maturitas.</i> 2014; <b>77</b>(2): 1637. <a target=xrefwindow id=d39351e2393 href="http://www.ncbi.nlm.nih.gov/pubmed/24269065">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2396 href="http://dx.doi.org/10.1016/j.maturitas.2013.10.015">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d39351e2405 class=n-a></a>Chand AL, Ponnampalam AP, Harris SE, <i> et al.</i>: Mutational analysis of <i>BMP15</i> and <i>GDF9</i> as candidate genes for premature ovarian failure. <i>Fertil Steril.</i> 2006; <b>86</b>(4): 100912. <a target=xrefwindow id=d39351e2423 href="http://www.ncbi.nlm.nih.gov/pubmed/17027369">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2426 href="http://dx.doi.org/10.1016/j.fertnstert.2006.02.107">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d39351e2435 class=n-a></a>Christin-Maitre S, Tachdjian G: Genome-wide association study and premature ovarian failure. <i>Ann Endocrinol (Paris).</i> 2010; <b>71</b>(3): 21821. <a target=xrefwindow id=d39351e2443 href="http://www.ncbi.nlm.nih.gov/pubmed/20362963">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2446 href="http://dx.doi.org/10.1016/j.ando.2010.02.014">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d39351e2456 class=n-a></a>Fassnacht W, Mempel A, Strowitzki T, <i> et al.</i>: Premature ovarian failure (POF) syndrome: towards the molecular clinical analysis of its genetic complexity. <i>Curr Med Chem.</i> 2006; <b>13</b>(12): 1397410. <a target=xrefwindow id=d39351e2467 href="http://www.ncbi.nlm.nih.gov/pubmed/16719785">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2470 href="http://dx.doi.org/10.2174/092986706776872943">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d39351e2479 class=n-a></a>Aittomki K, Lucena JL, Pakarinen P, <i> et al.</i>: Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. <i>Cell.</i> 1995; <b>82</b>(6): 95968. <a target=xrefwindow id=d39351e2490 href="http://www.ncbi.nlm.nih.gov/pubmed/7553856">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2493 href="http://dx.doi.org/10.1016/0092-8674(95)90275-9">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d39351e2502 class=n-a></a>Woad KJ, Prendergast D, Winship IM, <i> et al.</i>: FSH receptor gene variants are rarely associated with premature ovarian failure. <i>Reprod Biomed Online.</i> 2013; <b>26</b>(4): 3969. <a target=xrefwindow id=d39351e2513 href="http://www.ncbi.nlm.nih.gov/pubmed/23419799">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2516 href="http://dx.doi.org/10.1016/j.rbmo.2013.01.004">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d39351e2525 class=n-a></a>Carter NP: Methods and strategies for analyzing copy number variation using DNA microarrays. <i>Nat Genet.</i> 2007; <b>39</b>(7 Suppl): S1621. <a target=xrefwindow id=d39351e2533 href="http://www.ncbi.nlm.nih.gov/pubmed/17597776">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2536 href="http://dx.doi.org/10.1038/ng2028">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2539 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2697494">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725507139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2548 class=n-a></a>Fonseca DJ, Patio LC, Surez YC, <i> et al.</i>: Next generation sequencing in women affected by nonsyndromic premature ovarian failure displays new potential causative genes and mutations. <i>Fertil Steril.</i> 2015; <b>104</b>(1): 15462.e2. <a target=xrefwindow id=d39351e2559 href="http://www.ncbi.nlm.nih.gov/pubmed/25989972">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2562 href="http://dx.doi.org/10.1016/j.fertnstert.2015.04.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725507139">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d39351e2575 class=n-a></a>Laissue P: Aetiological coding sequence variants in non-syndromic premature ovarian failure: From genetic linkage analysis to next generation sequencing. <i>Mol Cell Endocrinol.</i> 2015; <b>411</b>: 24357. <a target=xrefwindow id=d39351e2583 href="http://www.ncbi.nlm.nih.gov/pubmed/25960166">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2586 href="http://dx.doi.org/10.1016/j.mce.2015.05.005">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d39351e2596 class=n-a></a>Caburet S, Arboleda VA, Llano E, <i> et al.</i>: Mutant cohesin in premature ovarian failure. <i>N Engl J Med.</i> 2014; <b>370</b>(10): 9439. <a target=xrefwindow id=d39351e2607 href="http://www.ncbi.nlm.nih.gov/pubmed/24597867">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2610 href="http://dx.doi.org/10.1056/NEJMoa1309635">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2614 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4068824">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d39351e2623 class=n-a></a>Wood-Trageser MA, Gurbuz F, Yatsenko SA, <i> et al.</i>: <i>MCM9</i> mutations are associated with ovarian failure, short stature, and chromosomal instability. <i>Am J Hum Genet.</i> 2014; <b>95</b>(6): 75462. <a target=xrefwindow id=d39351e2637 href="http://www.ncbi.nlm.nih.gov/pubmed/25480036">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2641 href="http://dx.doi.org/10.1016/j.ajhg.2014.11.002">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2644 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4259971">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d39351e2653 class=n-a></a>Tucker EJ, Grover SR, Bachelot A, <i> et al.</i>: Premature Ovarian Insufficiency: New Perspectives on Genetic Cause and Phenotypic Spectrum. <i>Endocr Rev.</i> 2016; <b>37</b>(6): 60935. <a target=xrefwindow id=d39351e2664 href="http://www.ncbi.nlm.nih.gov/pubmed/27690531">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2667 href="http://dx.doi.org/10.1210/er.2016-1047">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d39351e2676 class=n-a></a>Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. <i>Cell.</i> 2004; <b>116</b>(2): 28197. <a target=xrefwindow id=d39351e2684 href="http://www.ncbi.nlm.nih.gov/pubmed/14744438">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2687 href="http://dx.doi.org/10.1016/S0092-8674(04)00045-5">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d39351e2696 class=n-a></a>Kuang H, Han D, Xie J, <i> et al.</i>: Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model. <i>Gynecol Endocrinol.</i> 2014; <b>30</b>(1): 5761. <a target=xrefwindow id=d39351e2707 href="http://www.ncbi.nlm.nih.gov/pubmed/24188450">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2710 href="http://dx.doi.org/10.3109/09513590.2013.850659">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d39351e2719 class=n-a></a>Yang X, Zhou Y, Peng S, <i> et al.</i>: Differentially expressed plasma microRNAs in premature ovarian failure patients and the potential regulatory function of mir-23a in granulosa cell apoptosis. <i>Reproduction.</i> 2012; <b>144</b>(2): 23544. <a target=xrefwindow id=d39351e2730 href="http://www.ncbi.nlm.nih.gov/pubmed/22653319">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2733 href="http://dx.doi.org/10.1530/REP-11-0371">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725312123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2743 class=n-a></a>Dang Y, Zhao S, Qin Y, <i> et al.</i>: MicroRNA-22-3p is down-regulated in the plasma of Han Chinese patients with premature ovarian failure. <i>Fertil Steril.</i> 2015; <b>103</b>(3): 8027.e1. <a target=xrefwindow id=d39351e2754 href="http://www.ncbi.nlm.nih.gov/pubmed/25585503">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2757 href="http://dx.doi.org/10.1016/j.fertnstert.2014.12.106">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725312123">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d39351e2770 class=n-a></a>Di Pasquale E, Beck-Peccoz P, Persani L: Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (<i>BMP15</i>) gene. <i>Am J Hum Genet.</i> 2004; <b>75</b>(1): 10611. <a target=xrefwindow id=d39351e2781 href="http://www.ncbi.nlm.nih.gov/pubmed/15136966">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2784 href="http://dx.doi.org/10.1086/422103">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2788 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1181993">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d39351e2797 class=n-a></a>Wu X, Wang B, Dong Z, <i> et al.</i>: A <i>NANOS3</i> mutation linked to protein degradation causes premature ovarian insufficiency. <i>Cell Death Dis.</i> 2013; <b>4</b>(10): e825. <a target=xrefwindow id=d39351e2811 href="http://www.ncbi.nlm.nih.gov/pubmed/24091668">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2815 href="http://dx.doi.org/10.1038/cddis.2013.368">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2818 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3824677">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d39351e2827 class=n-a></a>LaBarbera AR, Miller MM, Ober C, <i> et al.</i>: Autoimmune etiology in premature ovarian failure. <i>Am J Reprod Immunol Microbiol.</i> 1988; <b>16</b>(3): 11522. <a target=xrefwindow id=d39351e2838 href="http://www.ncbi.nlm.nih.gov/pubmed/3289410">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2841 href="http://dx.doi.org/10.1111/j.1600-0897.1988.tb00180.x">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732146090"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e2850 class=n-a></a>Ayesha, Jha V, Goswami D: Premature Ovarian Failure: An Association with Autoimmune Diseases. <i>J Clin Diagn Res.</i> 2016; <b>10</b>(10): QC10QC12. <a target=xrefwindow id=d39351e2858 href="http://www.ncbi.nlm.nih.gov/pubmed/27891401">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2861 href="http://dx.doi.org/10.7860/JCDR/2016/22027.8671">Publisher Full Text </a> | <a target=xrefwindow id=d39351e2864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5121739">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732146090">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d39351e2877 class=n-a></a>Goswami R, Marwaha RK, Goswami D, <i> et al.</i>: Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. <i>J Clin Endocrinol Metab.</i> 2006; <b>91</b>(11): 42569. <a target=xrefwindow id=d39351e2888 href="http://www.ncbi.nlm.nih.gov/pubmed/16895958">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2891 href="http://dx.doi.org/10.1210/jc.2006-1005">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d39351e2901 class=n-a></a>Lebovic D, Naz R: Premature ovarian failure: Think ?autoimmune disorder? <i>Sexuality Reproduction and Menopause.</i> 2004; <b>2</b>(4): 2303. <a target=xrefwindow id=d39351e2909 href="http://dx.doi.org/10.1016/j.sram.2004.11.010">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d39351e2918 class=n-a></a>Bakalov VK, Vanderhoof VH, Bondy CA, <i> et al.</i>: Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. <i>Hum Reprod.</i> 2002; <b>17</b>(8): 2096100. <a target=xrefwindow id=d39351e2929 href="http://www.ncbi.nlm.nih.gov/pubmed/12151443">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2932 href="http://dx.doi.org/10.1093/humrep/17.8.2096">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d39351e2941 class=n-a></a>Silva CA, Yamakami LY, Aikawa NE, <i> et al.</i>: Autoimmune primary ovarian insufficiency. <i>Autoimmun Rev.</i> 2014; <b>13</b>(45): 42730. <a target=xrefwindow id=d39351e2952 href="http://www.ncbi.nlm.nih.gov/pubmed/24418305">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2955 href="http://dx.doi.org/10.1016/j.autrev.2014.01.003">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d39351e2964 class=n-a></a>Anasti JN: Premature ovarian failure: an update. <i>Fertil Steril.</i> 1998; <b>70</b>(1): 115. <a target=xrefwindow id=d39351e2972 href="http://www.ncbi.nlm.nih.gov/pubmed/9660412">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2975 href="http://dx.doi.org/10.1016/S0015-0282(98)00099-5">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d39351e2984 class=n-a></a>Panay N, Kalu E: Management of premature ovarian failure. <i>Best Pract Res Clin Obstet Gynaecol.</i> 2009; <b>23</b>(1): 12940. <a target=xrefwindow id=d39351e2992 href="http://www.ncbi.nlm.nih.gov/pubmed/19091633">PubMed Abstract </a> | <a target=xrefwindow id=d39351e2995 href="http://dx.doi.org/10.1016/j.bpobgyn.2008.10.008">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d39351e3004 class=n-a></a>Ebrahimi M, Akbari Asbagh F: Pathogenesis and causes of premature ovarian failure: an update. <i>Int J Fertil Steril.</i> 2011; <b>5</b>(2): 5465. <a target=xrefwindow id=d39351e3012 href="http://www.ncbi.nlm.nih.gov/pubmed/24963360">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3015 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4059950">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13357012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3025 class=n-a></a>Rocca WA, Grossardt BR, Miller VM, <i> et al.</i>: Premature menopause or early menopause and risk of ischemic stroke. <i>Menopause.</i> 2012; <b>19</b>(3): 2727. <a target=xrefwindow id=d39351e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/21993082">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3039 href="http://dx.doi.org/10.1097/gme.0b013e31822a9937">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3258468">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13357012">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d39351e3056 class=n-a></a>Archer DF: Premature menopause increases cardiovascular risk. <i>Climacteric.</i> 2009; <b>12 Suppl 1</b>: 2631. <a target=xrefwindow id=d39351e3064 href="http://www.ncbi.nlm.nih.gov/pubmed/19811237">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3067 href="http://dx.doi.org/10.1080/13697130903013452">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727066125"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3076 class=n-a></a>Sullivan SD, Sarrel PM, Nelson LM: Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. <i>Fertil Steril.</i> 2016; <b>106</b>(7): 158899. <a target=xrefwindow id=d39351e3084 href="http://www.ncbi.nlm.nih.gov/pubmed/27912889">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3087 href="http://dx.doi.org/10.1016/j.fertnstert.2016.09.046">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3090 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5137796">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727066125">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d39351e3103 class=n-a></a>Kalantaridou SN, Naka KK, Papanikolaou E, <i> et al.</i>: Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(8): 390713. <a target=xrefwindow id=d39351e3114 href="http://www.ncbi.nlm.nih.gov/pubmed/15292326">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3117 href="http://dx.doi.org/10.1210/jc.2004-0015">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d39351e3126 class=n-a></a>Sarrel PM, Lindsay D, Rosano GM, <i> et al.</i>: Angina and normal coronary arteries in women: gynecologic findings. <i>Am J Obstet Gynecol.</i> 1992; <b>167</b>(2): 46771. <a target=xrefwindow id=d39351e3137 href="http://www.ncbi.nlm.nih.gov/pubmed/1497053">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3140 href="http://dx.doi.org/10.1016/S0002-9378(11)91431-8">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d39351e3149 class=n-a></a>Vujovic S, Brincat M, Erel T, <i> et al.</i>: EMAS position statement: Managing women with premature ovarian failure. <i>Maturitas.</i> 2010; <b>67</b>(1): 913. <a target=xrefwindow id=d39351e3160 href="http://www.ncbi.nlm.nih.gov/pubmed/20605383">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3163 href="http://dx.doi.org/10.1016/j.maturitas.2010.04.011">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726891150"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3173 class=n-a></a>Santoro N, Allshouse A, Neal-Perry G, <i> et al.</i>: Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. <i>Menopause.</i> 2017; <b>24</b>(3): 23846. <a target=xrefwindow id=d39351e3184 href="http://www.ncbi.nlm.nih.gov/pubmed/27779568">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3187 href="http://dx.doi.org/10.1097/GME.0000000000000756">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3191 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5323337">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726891150">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726253942"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3204 class=n-a></a>Hodis HN, Mack WJ, Henderson VW, <i> et al.</i>: Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. <i>N Engl J Med.</i> 2016; <b>374</b>(13): 122131. <a target=xrefwindow id=d39351e3215 href="http://www.ncbi.nlm.nih.gov/pubmed/27028912">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3218 href="http://dx.doi.org/10.1056/NEJMoa1505241">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4921205">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726253942">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d39351e3235 class=n-a></a>Gallagher JC: Effect of early menopause on bone mineral density and fractures. <i>Menopause.</i> 2007; <b>14</b>(3 Pt 2): 56771. <a target=xrefwindow id=d39351e3243 href="http://www.ncbi.nlm.nih.gov/pubmed/17476146">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3246 href="http://dx.doi.org/10.1097/gme.0b013e31804c793d">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d39351e3255 class=n-a></a>Popat VB, Calis KA, Vanderhoof VH, <i> et al.</i>: Bone mineral density in estrogen-deficient young women. <i>J Clin Endocrinol Metab.</i> 2009; <b>94</b>(7): 227783. <a target=xrefwindow id=d39351e3266 href="http://www.ncbi.nlm.nih.gov/pubmed/19401379">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3269 href="http://dx.doi.org/10.1210/jc.2008-1878">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3273 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2708959">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d39351e3282 class=n-a></a>van Der Voort DJ, van Der Weijer PH, Barentsen R: Early menopause: increased fracture risk at older age. <i>Osteoporos Int.</i> 2003; <b>14</b>(6): 52530. <a target=xrefwindow id=d39351e3290 href="http://www.ncbi.nlm.nih.gov/pubmed/12730751">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3293 href="http://dx.doi.org/10.1007/s00198-003-1408-1">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725890649"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3302 class=n-a></a>Hewlett M, Mahalingaiah S: Update on primary ovarian insufficiency. <i>Curr Opin Endocrinol Diabetes Obes.</i> 2015; <b>22</b>(6): 4839. <a target=xrefwindow id=d39351e3310 href="http://www.ncbi.nlm.nih.gov/pubmed/26512773">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3313 href="http://dx.doi.org/10.1097/MED.0000000000000206">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3316 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4883575">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725890649">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d39351e3330 class=n-a></a>Bove R, Secor E, Chibnik LB, <i> et al.</i>: Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. <i>Neurology.</i> 2014; <b>82</b>(3): 2229. <a target=xrefwindow id=d39351e3341 href="http://www.ncbi.nlm.nih.gov/pubmed/24336141">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3344 href="http://dx.doi.org/10.1212/WNL.0000000000000033">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3348 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3902759">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d39351e3357 class=n-a></a>Phung TK, Waltoft BL, Laursen TM, <i> et al.</i>: Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study. <i>Dement Geriatr Cogn Disord.</i> 2010; <b>30</b>(1): 4350. <a target=xrefwindow id=d39351e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/20689282">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3371 href="http://dx.doi.org/10.1159/000314681">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d39351e3380 class=n-a></a>Rocca WA, Grossardt BR, Shuster LT: Oophorectomy, estrogen, and dementia: a 2014 update. <i>Mol Cell Endocrinol.</i> 2014; <b>389</b>(12): 712. <a target=xrefwindow id=d39351e3388 href="http://www.ncbi.nlm.nih.gov/pubmed/24508665">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3391 href="http://dx.doi.org/10.1016/j.mce.2014.01.020">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3394 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4040304">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d39351e3403 class=n-a></a>Schmidt PJ, Cardoso GM, Ross JL, <i> et al.</i>: Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. <i>JAMA.</i> 2006; <b>295</b>(12): 13746. <a target=xrefwindow id=d39351e3414 href="http://www.ncbi.nlm.nih.gov/pubmed/16551707">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3417 href="http://dx.doi.org/10.1001/jama.295.12.1374">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d39351e3426 class=n-a></a>Nelson LM, Anasti JN, Kimzey LM, <i> et al.</i>: Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. <i>J Clin Endocrinol Metab.</i> 1994; <b>79</b>(5): 14705. <a target=xrefwindow id=d39351e3437 href="http://www.ncbi.nlm.nih.gov/pubmed/7962345">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3440 href="http://dx.doi.org/10.1210/jcem.79.5.7962345">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d39351e3449 class=n-a></a>van Kasteren YM, Schoemaker J: Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. <i>Hum Reprod Update.</i> 1999; <b>5</b>(5): 48392. <a target=xrefwindow id=d39351e3457 href="http://www.ncbi.nlm.nih.gov/pubmed/10582785">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3460 href="http://dx.doi.org/10.1093/humupd/5.5.483">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d39351e3470 class=n-a></a>Practice Committee of American Society for Reproductive Medicine: Ovarian tissue cryopreservation: a committee opinion. <i>Fertil Steril.</i> 2014; <b>101</b>(5): 123743. <a target=xrefwindow id=d39351e3478 href="http://www.ncbi.nlm.nih.gov/pubmed/24684955">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3481 href="http://dx.doi.org/10.1016/j.fertnstert.2014.02.052">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d39351e3490 class=n-a></a>Ethics Committee of American Society for Reproductive Medicine: Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. <i>Fertil Steril.</i> 2013; <b>100</b>(5): 122431. <a target=xrefwindow id=d39351e3498 href="http://www.ncbi.nlm.nih.gov/pubmed/24094423">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3501 href="http://dx.doi.org/10.1016/j.fertnstert.2013.08.041">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726694304"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3510 class=n-a></a>Zhai J, Yao G, Dong F, <i> et al.</i>: <i>In Vitro</i> Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients. <i>J Clin Endocrinol Metab.</i> 2016; <b>101</b>(11): 440512. <a target=xrefwindow id=d39351e3524 href="http://www.ncbi.nlm.nih.gov/pubmed/27571179">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3528 href="http://dx.doi.org/10.1210/jc.2016-1589">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5095246">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726694304">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718128583"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3544 class=n-a></a>Kawamura K, Cheng Y, Suzuki N, <i> et al.</i>: Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(43): 174749. <a target=xrefwindow id=d39351e3555 href="http://www.ncbi.nlm.nih.gov/pubmed/24082083">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3558 href="http://dx.doi.org/10.1073/pnas.1312830110">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3562 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3808580">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718128583">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725301492"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3575 class=n-a></a>Suzuki N, Yoshioka N, Takae S, <i> et al.</i>: Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. <i>Hum Reprod.</i> 2015; <b>30</b>(3): 60815. <a target=xrefwindow id=d39351e3586 href="http://www.ncbi.nlm.nih.gov/pubmed/25567618">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3589 href="http://dx.doi.org/10.1093/humrep/deu353">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725301492">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727837217"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3602 class=n-a></a>Silvestris E, D'Oronzo S, Cafforio P, <i> et al.</i>: Perspective in infertility: the ovarian stem cells. <i>J Ovarian Res.</i> 2015; <b>8</b>: 55. <a target=xrefwindow id=d39351e3613 href="http://www.ncbi.nlm.nih.gov/pubmed/26250560">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3616 href="http://dx.doi.org/10.1186/s13048-015-0184-9">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3620 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4528806">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727837217">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1017989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3634 class=n-a></a>Johnson J, Canning J, Kaneko T, <i> et al.</i>: Germline stem cells and follicular renewal in the postnatal mammalian ovary. <i>Nature.</i> 2004; <b>428</b>(6979): 14550. <a target=xrefwindow id=d39351e3645 href="http://www.ncbi.nlm.nih.gov/pubmed/15014492">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3648 href="http://dx.doi.org/10.1038/nature02316">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1017989">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725738469"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3661 class=n-a></a>Grieve KM, McLaughlin M, Dunlop CE, <i> et al.</i>: The controversial existence and functional potential of oogonial stem cells. <i>Maturitas.</i> 2015; <b>82</b>(3): 27881. <a target=xrefwindow id=d39351e3672 href="http://www.ncbi.nlm.nih.gov/pubmed/26278874">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3675 href="http://dx.doi.org/10.1016/j.maturitas.2015.07.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725738469">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13945979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3688 class=n-a></a>White YA, Woods DC, Takai Y, <i> et al.</i>: Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. <i>Nat Med.</i> 2012; <b>18</b>(3): 41321. <a target=xrefwindow id=d39351e3699 href="http://www.ncbi.nlm.nih.gov/pubmed/22366948">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3702 href="http://dx.doi.org/10.1038/nm.2669">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3706 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3296965">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13945979">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d39351e3719 class=n-a></a>Stimpfel M, Skutella T, Cvjeticanin B, <i> et al.</i>: Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries. <i>Cell Tissue Res.</i> 2013; <b>354</b>(2): 593607. <a target=xrefwindow id=d39351e3730 href="http://www.ncbi.nlm.nih.gov/pubmed/23820736">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3733 href="http://dx.doi.org/10.1007/s00441-013-1677-8">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d39351e3742 class=n-a></a>Dunlop CE, Telfer EE, Anderson RA: Ovarian stem cells--potential roles in infertility treatment and fertility preservation. <i>Maturitas.</i> 2013; <b>76</b>(3): 27983. <a target=xrefwindow id=d39351e3750 href="http://www.ncbi.nlm.nih.gov/pubmed/23693139">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3753 href="http://dx.doi.org/10.1016/j.maturitas.2013.04.017">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d39351e3762 class=n-a></a>Wassertheil-Smoller S, Hendrix SL, Limacher M, <i> et al.</i>: Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. <i>JAMA.</i> 2003; <b>289</b>(20): 267384. <a target=xrefwindow id=d39351e3773 href="http://www.ncbi.nlm.nih.gov/pubmed/12771114">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3776 href="http://dx.doi.org/10.1001/jama.289.20.2673">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726699724"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3786 class=n-a></a>Hipp HS, Charen KH, Spencer JB, <i> et al.</i>: Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). <i>Menopause.</i> 2016; <b>23</b>(9): 9939. <a target=xrefwindow id=d39351e3797 href="http://www.ncbi.nlm.nih.gov/pubmed/27552334">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3800 href="http://dx.doi.org/10.1097/GME.0000000000000658">Publisher Full Text </a> | <a target=xrefwindow id=d39351e3804 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4998843">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726699724">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717954966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3817 class=n-a></a>Furness S, Roberts H, Marjoribanks J, <i> et al.</i>: Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. <i>Cochrane Database Syst Rev.</i> 2012; (8): CD000402. <a target=xrefwindow id=d39351e3825 href="http://www.ncbi.nlm.nih.gov/pubmed/22895916">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3828 href="http://dx.doi.org/10.1002/14651858.CD000402.pub4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717954966">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1159098"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d39351e3841 class=n-a></a>Langrish JP, Mills NL, Bath LE, <i> et al.</i>: Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. <i>Hypertension.</i> 2009; <b>53</b>(5): 80511. <a target=xrefwindow id=d39351e3852 href="http://www.ncbi.nlm.nih.gov/pubmed/19332659">PubMed Abstract </a> | <a target=xrefwindow id=d39351e3855 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.108.126516">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1159098">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2069&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2069&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics &amp; Gynecology, Womack Army Medical Center, Fort Bragg, North Carolina, USA<br/> <sup>2</sup> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA<br/> <p> <div class=margin-bottom> Saioa Torrealday <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Pinar Kodaman <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Lubna Pal <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2069/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Nov 2017, 6:2069 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11948.1">https://doi.org/10.12688/f1000research.11948.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Torrealday S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12914 data-id=11948 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11948.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2069/v1/pdf?article_uuid=61c360ed-cf5c-449c-a9e7-ad9acca78b39" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11948.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Torrealday S, Kodaman P and Pal L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management [version 1; peer review: 3 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2069 (<a href="https://doi.org/10.12688/f1000research.11948.1" target=_blank>https://doi.org/10.12688/f1000research.11948.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11948 id=mobile-track-article-signin-11948 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11948?target=/articles/6-2069"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12914 /> <input name=articleId type=hidden value=11948 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>James H. Liu</strong>, Case Western Reserve University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Zi-Jiang Chen</strong>, Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Corrine K. Welt</strong>, Division of Endocrinology, Metabolism and Diabetes, University of Utah, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2069&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2069&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28390-28316></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=11187-28318></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28389-28317></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2069/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Nov 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>James H. Liu</strong>, Case Western Reserve University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Zi-Jiang Chen</strong>, Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Corrine K. Welt</strong>, Division of Endocrinology, Metabolism and Diabetes, University of Utah, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2069&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2069/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Premature Ovarian Insufficiency - an update...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2069/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2069/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2069/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Torrealday S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2069/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2069",
            templates : {
                twitter : "Premature Ovarian Insufficiency - an update on recent advances.... Torrealday S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2069/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Premature Ovarian Insufficiency - an update on recent advances in understanding and management", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Premature Ovarian Insufficiency - an update on recent advances in understanding and management", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11948/12914")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12914");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28316": 0,
                           "28317": 0,
                           "28318": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "f056d71a-061e-47b3-b016-71ee669a11da";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2069.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2069.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2069.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2069.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2069.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>